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MicroRNA-target interactions in neurodegenerative diseases
Hermona Soreq
The Hebrew University of Jerusalem, Israel
SpringerPlus 2015, 4(Suppl 1):L1
MicroRNAs (miRNAs) are short, 22–25 nucleotide long transcripts 
that may suppress entire signaling pathways by interacting with the 
3’-untranslated region (3’-UTR) of coding mRNA targets, interrupting 
translation and inducing degradation of these targets. The long 3’-UTRs 
of brain transcripts compared to other tissues predict important roles 
for brain miRNAs. Supporting this notion, we found that brain miRNAs 
co-evolved with their target transcripts, that non-coding pseudogenes 
with miRNA recognition elements compete with brain coding mRNAs 
on their miRNA interactions, and that Single Nucleotide Polymorphisms 
(SNPs) on such pseudogenes are enriched in mental diseases including 
autism and schizophrenia, but not Alzheimer’s disease (AD). Focusing 
on evolutionarily conserved and primate-specifi c miRNA controllers 
of cholinergic signaling (‘CholinomiRs’), we fi nd modifi ed CholinomiR 
levels in the brain and/or nucleated blood cells of patients with AD 
and Parkinson’s disease, with treatment-related diff erences in their 
levels and prominent impact on the cognitive and anti-infl ammatory 
consequences of cholinergic signals. Examples include the acetyl-
cholinesterase (AChE)-targeted evolutionarily conserved miR-132, 
whose levels decline drastically in the AD brain. Furthermore, we 
found that interruption of AChE mRNA’s interaction with the primate-
specifi c CholinomiR-608 in carriers of a SNP in the AChE’s miR-608 
binding site induces domino-like eff ects that reduce the levels of many 
other miR-608 targets. Young, healthy carriers of this SNP express 
40% higher brain AChE activity than others, potentially aff ecting the 
responsiveness to AD’s anti-AChE therapeutics, and show elevated trait 
anxiety, infl ammation and hypertension. Non-coding regions aff ecting 
miRNA-target interactions in neurodegenerative brains thus merit 
special attention.
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Reacquisition of cocaine conditioned place preference and its 
inhibition by previous social interaction: Neurochemical and 
electrophysiological correlates in the nucleus accumbens corridor
Alois Saria, Janine Prast, Aurelia Schardl, Kai Kummer
Experimental Psychiatry Unit, Medical University Innsbruck, Austria
SpringerPlus 2015, 4(Suppl 1):L2
The nucleus accumbens has long been a major target for studies on 
the rewarding eff ects of drugs of abuse or physiological reinforcers, 
whereas the brain regions medial of the medial accumbens shell have 
received less attention. We investigated if counterconditioning with 
dyadic (i.e., one-to-one) social interaction, a strong inhibitor of the 
subsequent reacquisition of cocaine conditioned place preference 
(CPP), diff erentially modulates the activity of the diverse brain 
regions oriented along a mediolateral corridor reaching from the 
interhemispheric sulcus to the anterior commissure, i.e., the nucleus 
of the vertical limb of the diagonal band, the medial septal nucleus, 
the major island of Calleja, the intermediate part of the lateral septal 
nucleus, and the medial accumbens shell and core. EGR1 activation was 
predominantly found in dynorphin-labeled cells, i.e., presumably D1 
receptor-expressing medium spiny neurons (D1-MSNs), with D2-MSNs 
(immunolabeled with an anti-DRD2 antibody) being less aff ected. 
Cholinergic interneurons or GABAergic interneurons positive for 
parvalbumin, neuropeptide Y or calretinin were not involved in these 
CPP-related EGR1 changes. Glial cells did not show any EGR1 expression 
either. Cocaine conditioning increased the spike frequency of neurons 
in the septal nuclei, whereas social interaction conditioning increased 
the spike frequency in the nucleus accumbens compared to saline 
control animals. In addition, social interaction conditioning decreased 
the amount of active neuron clusters in the nucleus accumbens.The 
present findings could be of relevance for the therapy of impaired 
social interaction in substance use disorders, depression, psychosis, 
and autism spectrum disorders.
Acknowledgements This work was supported by the Austrian Science 
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Copper metabolism of astrocytes
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Copper is an essential trace element which is involved in many impor-
tant cellular functions [1]. However, excess of copper can impair cellular 
functions by copper-induced oxidative stress. In brain, astrocytes are 
considered to play a prominent role in antioxidative defence as well 
as in the copper homeostasis [1,2]. To investigate uptake, toxicity, 
storage and export of copper in astrocytes, we used primary rat 
astrocyte cultures as model system. Cultured astrocytes effi  ciently 
take up copper ions predominantly by the copper transporter Ctr1 
and the divalent metal transporter DMT1. In addition, copper oxide 
nanoparticles are rapidly accumulated by astrocytes, most likely by 
endocytotic processes. Astrocytes tolerate moderate increases in 
intracellular copper contents very well. However, if the specifi c cellular 
copper content exceeds after exposure to copper or copper oxide 
nanoparticles a threshold level of around 10 nmol copper/mg protein, 
accelerated production of reactive oxygen species and compromised 
cell viability were observed. Upon exposure to sub-toxic concentrations 
of copper ions or copper oxide nanoparticles, astrocytes increase 
their copper storage capacity by upregulating the cellular contents 
of glutathione and metallothioneins. In addition, cultured astrocytes 
have the capacity to export copper ions which is likely to involve the 
copper-transporting ATPase 7A. The ability of astrocytes to effi  ciently 
accumulate, store and export copper ions suggests that astrocytes 
play a key role in brain copper homeostasis and that an impairment of 
astrocytic functions may be involved in diseases which are connected 
with disturbances in brain copper metabolism.
Keywords Astrocytes, metals, oxidative stress
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Altered developmental neuroplasticity due to polysialyltransferase 
ST8SiaII defi ciency in mice leads to schizophrenia-like phenotype
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Post-translational modifi cation of the neural cell adhesion molecule 
(NCAM) by polysialic acid (PSA) is crucial for nervous system 
development and brain plasticity. PSA attachment is catalyzed by 
the two polysialyltransferases, ST8SiaII and ST8SiaIV. ST8SiaII domi-
nates during embryonic and early postnatal development while 
ST8SiaIV is the prevailing enzyme of the juvenile and adult brain. A 
growing body of evidence links aberrant levels of NCAM and PSA to 
neuropsychiatric disorders, including schizophrenia. To investigate 
whether polysialyltransferase defi ciency might cause a schizophrenia-
like phenotype, ST8SiaII–/– mice, ST8SiaIV–/– mice and their wild-type 
littermates were assessed neuroanatomically and subjected to tests 
of cognition and sensory functions. ST8SiaII–/– but not ST8SiaIV–/– 
mice displayed enlarged lateral ventricles and a size reduction of the 
thalamus accompanied by a smaller internal capsule and a highly 
disorganized pattern of thalamocortical and corticothalamic fi bers. 
Loss of ST8SiaII was associated with reduced phosphorylation of 
fi broblast growth factor receptor 1 in the frontal cortex of newborn 
mice and retarded neuronal diff erentiation of newly generated cells 
in the dentate gyrus of adults. ST8SiaII–/– and ST8SiaIV–/– mice were 
both impaired in short- and long-term recognition memory, but only 
ST8SiaII–/– mice displayed impaired working memory and a defi cit in 
prepulse inhibition, which could be attenuated by clozapine treatment. 
Furthermore, ST8SiaII–/– mice exhibited anhedonic behavior and 
increased sensitivity to amphetamine-induced hyperlocomotion. 
These data reveal that reduced polysialylation in ST8SiaII–/– mice leads 
to pathological brain development and schizophrenia-like behavior. 
We therefore propose that ST8SiaII defi ciency has the potential to 
cause a neurodevelopmental predisposition to schizophrenia.
Acknowledgements The study was supported by the EU 6FWP grant 
LSHM-CT-2005-512012.
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G protein–coupled receptors (GPCRs) are intensely studied as drug 
targets and for their role in signaling. High-resolution crystal structures 
of GPCRs capturing diff erent receptor conformations are now available, 
which have provided insights into the mechanism of activation and 
ligand selectivity for this important class of drug targets. I will fi rst 
present a series of structure-based screens for novel ligands of the 
A2A adenosine receptor (A2AAR), which is a drug target for Parkinson’s 
disease (antagonists) and ischemia (agonists). As crystal structures for 
both inactive- and active-like receptor conformations of the A2AAR have 
now been determined, molecular docking screens for novel ligands 
can be performed. Virtual screens against diff erent conformations of 
the A2AAR were carried out to investigate if structure-based methods 
can be used to identify agonists and antagonists. Our results shed light 
on the importance of access to crystal structures and the role of the 
chemical library in screens for ligands with specifi c pharmacological 
properties. For most GPCRs, no experimental coordinates are available 
and structure-based screens are forced to rely on homology models. 
However, it is still unclear if models of GPCRs are suffi  ciently accurate 
to be used in ligand discovery. The determination of crystal structures 
for dopamine and serotonin receptors, and the challenges to the 
community to predict these in the GPCR Dock competitions, have 
enabled us to carry out comparisons of ligand discovery from models 
versus crystal structures. Our results from these challenges reveal 
opportunities and limitations of the use of homology models in ligand 
discovery and design of selective lead candidates.
Acknowledgements Symposium organized by COST action 
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Comparison of A1 and A2A receptor dynamics using FRET based 
receptor sensors
Carsten Hoff mann, Anette Stumpf
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Recently published crystal structures of the adenosine A2A receptor 
in the active and inactive state have revealed static endpoints of the 
conformational changes associated with the activation process. To 
investigate the activation dynamics of diff erent adenosine receptor 
subtypes we used fl uorescence resonance energy transfer (FRET) 
measurements of a modifi ed A1 and A2A receptor construct (A1R, 
A2AR). Those optical probes where designed by fusion of the cyan 
fl uorescent protein (CFP) to the C-terminus of the receptor and 
insertion of the fl uorescein arsenical hairpin binder (FlAsH) motif into 
the 3rd intracellular loop. Based on the ligand binding pocket revealed 
from the crystal structure 10 optical probes including individual 
mutations were created for each receptor. To compare A1R and A2AR 
dynamics, we established HEK293 cell lines stably expressing these 
optical probes and investigated the signal amplitude and the receptor 
activation kinetics in living cells. We indentifi ed 3 diff erent eff ects of 
these mutations. One class causes problems in membrane localization 
of the A1R but not the A2AR. The 2nd group is involved in binding of 
the ribose moiety and has stronger eff ects in the A1R compared to the 
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A2AR. The 3rd class consists of the mutants that are involved in binding 
of the adenine moiety and have similar eff ects for adenosine and 
theophylline binding for the A2AR. Thus, our study provides evidence 
that amino acids serve diff erent functions within the A1R and A2AR 
ligand binding pocket. In summary the diff erent signal amplitudes 
and diff erent activation kinetics are indicative for a diff erent activation 
behavior of the A1R and A2AR and the data from the receptor mutants 
support these fi ndings and gives new insight into the A1R- structure.
Acknowledgements Symposium organized by COST action 
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Defi ning the organizational structure of dopamine and muscarninic 
acetylcholine receptors
Graeme Milligan1, María José Varela Liste1, 
Gianluigi Caltabiano Caltabiano2, Elisa Alvarez-Curto1, Sara Marsango1
1University of Glasgow, UK; 2Universitat Autònoma de Barcelona, Spain
SpringerPlus 2015, 4(Suppl 1):L7
G protein-coupled receptors, including the M3 muscarinic acetylcholine 
receptor and the dopamine D3 receptor, can form homo-oligomers. 
However, the basis of these interactions and the overall organizational 
structure of such oligomers are poorly understood. Combinations 
of site-directed mutagenesis and homogenous time-resolved FRET 
studies that assessed interactions between receptor protomers at the 
surface of transfected cells indicated important contributions of regions 
of transmembrane domains I, IV, V, VI and VII, as well as intracellular 
helix VIII, to the overall organization. Molecular modelling studies 
based on both these results and an X-ray structure of the inactive 
state of the M3 receptor bound by the antagonist/inverse agonist 
tiotropium were then employed. The results could be accommodated 
fully by models in which a proportion of the cell surface M3 receptor 
population is a tetramer with rhombic, but not linear, orientation. This 
is consistent with previous studies based on spectrally-resolved, multi-
photon FRET. Modelling studies suggest, furthermore, an important 
role for molecules of cholesterol at the dimer + dimer interface of the 
tetramer, consistent with the presence of cholesterol at key locations 
in many G protein-coupled receptor crystal structures. Mutants that 
displayed disrupted quaternary organization were often poorly 
expressed and showed immature N-glycosylation. Sustained treatment 
of cells expressing such mutants with the muscarinic receptor inverse 
agonist atropine increased cellular levels and restored both cell surface 
delivery and quaternary organization to many of the mutants. These 
observations suggest that organization as a tetramer may occur before 
plasma membrane delivery and may be a key step in cellular quality 
control assessment.
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Stehen Hill
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Previous work, using fl uorescent adenosine receptor agonists and 
antagonists, has provided novel insights into the allosteric regulation 
of adenosine A3 (A3AR) and A1 (A1AR) receptors by allosteric ligands 
and receptor dimerization in single living cells [1,2]. We have also used 
a fl uorescent analogue of CGP12177 to investigate ligand binding to 
the human β1-adrenoceptor. This work has demonstrated that there 
is negative cooperativity between the two diff erent ligand-binding 
conformations of the β1-adrenoceptor activated by catecholamines 
and CGP12177 respectively [3]. Finally, we have used fl uorescence 
correlation spectroscopy (FCS) to investigate ligand binding to A1AR 
and A3AR in small 0.2  μm2 microdomains of single living cells [4]. 
FCS studies with a fl uorescent A3-agonist have enabled high affi  nity 
labeling of the active conformation (R*) of the receptor [4]. We have also 
used a fl uorescent adenosine A3-antagonist (CA200645) to study the 
binding characteristics of antagonist-occupied receptor conformations 
(R) in membrane microdomains of single cells [5]. Investigation of 
the dissociation kinetics of CA200645 provided further support for 
allosteric regulation of this receptor by homodimerization [5].
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Brain tumors represent a recognized cause of epilepsy in both 
children and adults. In principle, any tumor (extra-axial, intra-axial, 
benign or malignant, common or uncommon) can cause seizures. 
However, patients with supratentorial low-grade glial tumors are 
more likely to develop epilepsy. Several clinical studies emphasize 
that pharmacologically intractable epilepsy critically aff ects the 
daily life of patients with brain tumors, even if the tumor is under 
control. Recently, the term of long-term epilepsy associated tumour 
(LEAT) has been introduced. LEATs are low grade, slowly growing, 
cortically-based tumours which predominantly occur in young 
patients with long histories (often 2  years or more) of drug-resistant 
epilepsy. Glioneuronal tumors (GNT), including gangliogliomas (GG) 
and dysembryoplastic neuroepithelial tumors (DNTs), represent the 
most common tumor within the spectrum of LEAT. The advent of the 
neurosurgical treatment of epilepsy-associated brain lesions confi rmed 
the strong epileptogenicity of these tumor entities. Understanding 
the mechanisms that underlie epileptogenesis in LEATs is essential to 
identify new treatment targets and to develop an eff ective therapy. 
Mechanisms such as alterations of the balance between excitation 
and inhibition and alterations in neuron-glia interactions might be 
involved. Astroglial cells express functional receptors for a variety of 
neurotransmitters and may critically modulate synaptic transmission. 
In addition, an increasing number of observations indicate that pro-
epileptogenic infl ammatory pathways are activated in GNT and 
may contribute to the onset and progression of seizures. The recent 
advances and likely candidate mechanisms and molecules involved in 
tumor-associated epileptogenesis will be discussed.
Acknowledgements EA is supported by the National Epilepsy Fund – 
“Power of the Small”, the Hersenstichting Nederland (NEF 013-1) and 
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Extracellular nucleoside and nucleotides acting via adenosine/
P1 and nucleotide P2 (P2X/P2Y) purinoceptors are fundamental 
signaling molecules controlling the survival and proliferation of astro-
cytes and oligodendrocytes (Ceruti and Abbracchio, Adv Exp Med 
Biol. 2013;986:13). The malignant transformation of these cells to 
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progressively more aggressive tumors (respectively, astrocytomas and 
anaplastic glioblastoma, and glioblastoma multiforme, containing 
proliferating cells resembling Oligodendrocytes Precursor Cells, OPCs) 
confers growth advantage and chemoresistance. Characterization 
of the specifi c P1 and P2 receptors on these tumors may unveil new 
strategies to reduce cancer growth and/or promote diff erentiation to 
non-cancerous glial phenotypes. The adenosine A3 receptor (A3AR) 
has emerged as a potential target. Under hypoxia, a condition typical 
of gliomas’ core, A3AR mediates chemoresistance via the PKB/Akt 
pathway (leading to inactivation of the pro-apopototic Bad protein) 
and by upregulating matrix metalloproteinase-9, that degrades 
extracellular matrix and promotes migration of glioma cells towards 
healthy brain regions (Ceruti and Abbracchio, and ref therein). Thus, 
inhibition of A3AR with selective antagonists could represent an 
appealing therapeutic approach. More recently, the P2X7 receptor has 
been recently found to be over-expressed in grade IV human gliomas 
(Monif et al., J Infl ammation. 2014;11:25) and its blockade with the 
synthetic antagonist Brilliant Blue G decreased tumour cell number. 
Finally, treatment of human glioblastoma multiforme cells with UDP, 
UDP-glucose or LTD4, that act as agonists at the new P2Y-like GPR17 
receptor, reduced the formation of glioma spheres, suggesting that 
GPR17 stimulation on highly proliferating tumor OPCs may drive their 
diff erentiation to the oligodendroglial fate, negatively aff ecting both 
tumor proliferation and self-renewal (Dougherty et al., Cancer Res. 
2012;72:4856).
Keywords Cell diff erentiation, purinoceptors, new targets in glioma
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Bozena Kaminska, Aleksandra Ellert-Miklaszewska
Nencki Institute of Experimental Biology, Warsaw, Poland
SpringerPlus 2015, 4(Suppl 1):L11
Cannabinoids, originally derived from Cannabis sativa, as well as 
their endogenous and synthetic counterparts, were shown to induce 
apoptosis of glioma cells in vitro and tumour regression in vivo via 
their specifi c receptors, cannabinoid receptors CB1 and/or CB2. CB2 are 
abnormally expressed in human gliomas and glioma cell lines. Most of 
the analysed gliomas expressed signifi cant levels of CB2 receptor and the 
extent of CB2 expression in the tumour specimens was related to tumour 
malignancy. A synthetic cannabinoid, WIN 55,212-2, down-regulated 
the Akt and Erk signalling pathways in C6 glioma cells that resulted in 
reduction of phosphorylated Bad levels, mitochondrial depolarization 
and activation of caspase cascade leading to apoptosis. We examined 
whether synthetic cannabinoids with diff erent receptor specifi city: 
WIN55,212-2 (a non-selective CB1/CB2 agonist) and JWH133 (a CB2-
selective agonist) aff ect survival of four human glioma cell lines and three 
primary human glioma cell lines. WIN-55,212-2 decreased cell viability in 
all examined cell lines and induced cell death. Susceptibility of the cells 
to JWH133 treatment correlated with the CB2 expression. Cannabinoids 
triggered a decrease of mitochondrial membrane potential, cleavage of 
caspase-9 and eff ector caspases. Induction of cell death by cannabinoid 
treatment led to the generation of a pro-apoptotic sphingolipid 
ceramide and disruption of signalling pathways crucial for regulation of 
proliferation and survival. Increased ceramide levels induced ER-stress 
and autophagy in drug-treated glioblastoma cells. We conclude that 
cannabinoids are effi  cient inhibitors of human glioma cells growth, once 
the cells express specifi c type of cannabinoid receptor.
Acknowledgements Studies supported by a grant 2012/04/A/
NZ3/00630 from the National Science Center, Poland
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Integrins are a group of molecules expressed by various cells including 
glioma cells and endothelial cells within the tumor. There are 18 
known alpha and beta integrin subunits which form a heterodimer. 
Integrins regulate diff erent cellular processes such as proliferation, 
adhesion, motility and survival as shown in numerous preclinical 
models. Furthermore, integrins control the activity of the transforming 
growth factor (TGF)-beta pathway and are involved in the process of 
angiogenesis which is indispensable for continued tumor growth. 
Because of the high expression levels of some integrins on glioma 
cells and their numerous functions, inhibition of integrin signaling 
has been considered a promising strategy for the treatment of glioma 
patients. Besides blocking antibodies which are currently under clinical 
investigation in other cancer entities, the integrin inhibitor cilengitide 
has been tested within several trials in glioblastoma patients over the 
last years. Cilengitide is a cyclic RDG peptide which targets integrins 
alphvbeta3 and alphavbeta5. Based on the results of smaller, initial 
trials suggesting an activity of cilengitide against glioblastoma, 2 larger 
trials were subsequently performed. However, both trials, which 
combined temozolomide-based chemoradiation with cilengitide failed 
to demonstrate an improved outcome with the addition of cilengitide. 
Ongoing translational analyses suggest that integrin levels in the tumor 
tissue are neither prognostic nor predict response to cilengitide. While 
the clinical development of cilengitide has been stopped, integrin 
inhibition with more eff ective agents may still be a promising approach 
in clinical neurooncology.
Keywords Glioma, integrin, TGF-beta
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Alzheimer’s disease (AD) is a devastating neurodegenerative disease 
causing irreversible cognitive decline in the elderly. There is no 
disease-modifying therapy for this condition and the mechanisms 
underpinning neuronal dysfunction and neurodegeneration are 
unclear. Compromised cytoskeletal integrity within neurons is 
reported in AD. This is believed to result from loss-of-function of 
the microtubule-associated protein tau, which becomes hyper-
phosphorylated and deposits into neurofi brillary tangles in AD. We have 
developed a Drosophila model of tauopathy in which abnormal human 
tau mediates neuronal dysfunction characterised by microtubule 
destabilisation, axonal transport disruption, synaptic defects and 
behavioural impairments. Here we show that a microtubule-stabilising 
drug, NAPVSIPQ (NAP), prevents as well as reverses these phenotypes 
even after they have become established. Moreover, it does not alter 
abnormal tau levels indicating that it by-passes toxic tau altogether. 
Thus, microtubule stabilisation is a disease-modifying therapeutic 
strategy protecting against tau-mediated neuronal dysfunction, which 
holds great promise for tauopathies like AD.
Keywords Microtubule stabilisation, tau, NAP
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Current therapies for Alzheimer’s disease (AD) and related disorders 
have demonstrated very modest, symptomatic effi  cacy, leaving an 
unmet medical need for new, more eff ective therapies. While drug 
development eff orts in the last two decades have primarily focused 
on the amyloid cascade hypothesis, with disappointing results so 
far, tau-based strategies have received little attention until recently 
despite that the presence of extensive tau pathology is central to the 
disease. The discovery at the turn of the century of mutations within 
the tau gene that cause fronto-temporal dementia demonstrated 
that tau dysfunction was per se suffi  cient to cause neuronal loss and 
clinical dementia. Development of tau pathology is associated with 
progressive neuronal loss and cognitive decline and is the common 
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underlying cause of a group of neurodegenerative disorders collectively 
known as “tauopathies”. Tauopathies are clinically, morphologically 
and biochemically heterogeneous neurodegenerative diseases 
characterized by the deposition of abnormal tau protein in the brain. 
The neuropathological phenotypes are distinguished based on the 
involvement of diff erent anatomical areas, cell types and presence of 
distinct isoforms of tau in the pathological deposits. Thus, the spectrum 
of tauopathy entities expands beyond the traditionally discussed 
disease forms. Emerging evidence strongly suggests that accumulation 
of abnormal tau is mediated through spreading of seeds of the protein 
from cell to cell. This prion-like mechanism would support the concept 
that in AD brains, tau pathology iinitiates in a very small part of the 
brain many years before becoming symptomatic, spreading slowly 
and progressively to the whole brain following an anatomically 
defi ned pattern. Emerging therapeutic strategies aimed at treating the 
underlying causes of the tau pathology will be discussed, including 
some novel therapeutic approaches on the verge of providing new 
treatment paradigms in upcoming years.
Keywords Tau, Alzheimer, dementia
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Oligodendrocytes, the myelin forming cells of the CNS, enwrap neuronal 
axons and form multilamellar myelin sheets. They are derived from 
oligodendrocyte precursor cells which migrate from the subventricular 
zone into the diff erent regions of the brain. Diff erentiation from the 
early progenitor to the mature multiprocessed oligodendrocyte 
is characterized by diff erent morphological stages. To support cell 
morphology and establish and maintain the myelin membrane, an 
intact, spatially organized cytoskeleton with dynamic properties is 
essential. In particular microtubules and their associated proteins play 
an important role. A variety of microtubule binding proteins, including 
tau, are present in oligodendrocytes. Oligodendrocytes in culture 
express all six isoforms of tau which are developmentally regulated. Tau 
proteins are present in immature and mature oligodendrocytes and 
specifi cally prominent in the branching points of the cellular processes. 
Downregulation of tau impairs cell diff erentiation and the process of 
early myelination. In neurodegenerative diseases collectively termed 
tauopathies, fi brillary tau accumulations occur not only in neurons but 
also in glia. Tau positive coiled bodies originating in oligodendrocytes 
are characteristic for the brains of patients with frontotemporal 
dementias, such as corticobasal degeneration and progressive 
supranuclear palsy. These aggregates are further characterized by the 
presence of heat shock proteins and ubiquitin, indicating that stress 
situations are causally related to the pathogenesis. In this respect, 
proteasomal dysfunctions have been discussed to be involved in 
neurodegenerative disorders and the aging process. Data on the 
consequences of proteolytic stress in oligodendrocytes and the protein 
aggregation process will be presented. Our data demonstrate that an 
intact cytoskeleton is essential for cellular defense mechanisms.
Keywords Oligodendrocytes, microtubules, neurodegenerative diseases
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Tau is a classical microtubule-associated protein known to regulate 
microtubule stability in neurons. In our study, we have addressed 
the putative crosstalk between tau and End binding proteins  1 and 
3 (EB1/3), the core microtubule plus-end tracking proteins (+TIPs), 
in diff erentiating neuronal cells. We show that tau and EB proteins 
interact directly and that the cellular distribution and mobility of EB 
proteins depends on tau localization and expression levels. Moreover, 
our data reveal that tau is essential for the proper localization of EB1 
at the medial-distal region of the axon shaft in developing neurons. 
In summary, we provide evidence for a new function of tau protein 
as a direct regulator of EB1/3 proteins. This further indicates that the 
interplay between classical MAPs and core +TIPs may be important for 
the fi ne-tuned regulation of microtubule dynamics and stability during 
neuronal diff erentiation.
Keywords Tau, end binding proteins, microtubule dynamics
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Orexin/hypocretin peptides are central for the regulation of the 
sleep/arousal states, and have, in addition, a role in the regulation of 
e.g. metabolism, addiction, stress response and pain gating. Orexin 
responses are mediated by G-protein-coupled OX1 and OX2 orexin 
receptors. Orexin signaling (in diff erent cell types) is very versatile, 
ranging from excitation to induction of cell death. Orexin receptor 
coupling is promiscuous, engaging members of at least three 
diff erent families of G-proteins, namely Gi, Gs and Gq, and some 
non-G-protein mediators as well. Preferred G-protein-coupling of the 
receptors appears diff erent in diff erent tissues, but the mechanism 
determining this are unknown. The primary signal transducers of 
orexin receptors very eff ectively activate phosholipase cascades, 
including PLA2, PLC and PLD, and also PLC-diacylglycerol lipase-
mediated endocannabinoid generation. These cascades may play 
a signifi cant role in the regulation of K+ and non-selective cation 
channels, which are the eff ectors for the orexin-mediated neuronal 
excitation. In some cell types, orexin receptor stimulation induces 
programmed cell death. Some diff erent mechanisms for his have been 
proposed, but the picture is still incomplete. Orexin receptors have 
been a target for multiple drug discovery projects. Main focus has 
been on the antagonists, with insomnia as the indication. For agonist 
drugs there are some ongoing smaller academic and semi-academic 
projects. Use of orexin receptor agonists is suggested to be benefi cial 
in narcolepsy (as peptide replacement therapy) and putatively in other 
sleep/wakefulness disturbances, metabolic disorders and cancer.
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The eff ect of galanin is mediated through three GPCR subtypes, GalR1-
3. The limited number of specifi c ligands to the galanin receptor 
subtypes has hindered the understanding of the individual eff ects of 
each receptor subtype. This review summarizes the current data of the 
importance of the galanin receptor subtypes and receptor subtype 
specifi c agonists and antagonists and their involvement in diff erent 
biological and pathological functions.
Keywords Galanin, neuropeptide, ligand
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G protein coupled receptors (GPCR) comprise a large family of trans-
membrane proteins involved in the regulation of signal transduction 
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through the cell membrane in response to various extracellular stimuli. 
GPCR have become important targets of many drugs for treatments of 
very diff erent diseases. During the last decade several fl uorescence-
based methods have been implemented for the characterization 
of signal transduction via GPCRs, starting from ligand binding and 
including several steps leading up to a response on the level of gene 
regulation. We have proposed the fl uorescence anisotropy (FA) and 
fl uorescence intensity (FI) assay to investigate fl uorescent ligand 
binding properties to diff erent GPCRs (Veiksina et al., 2010). The 
implementations of budded baculoviruses that display G protein-
coupled receptors on their surfaces have signifi cantly increased 
sensitivity and applicability of these assays (Veiksina et al., 2014). The 
developed novel assay systems opened new possibilities for real-time 
monitoring of ligand binding to their receptors for understanding 
their particular kinetic properties. These assays are also compatible 
for homogenous HTS suitable fo ligand screening. There has been 
implemented assay systems for receptors of peptides like melanocortin 
(MC4R) and neuropeptide Y (NPY1R) as well as for receptors of 
monoamines like dopamine (D1DAR) and serotonin (5-HT1AR).
Acknowledgements This work has been fi nanced by Estonian Ministry 
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Objectives: The PET tracer [11C]ORM-13070 was recently validated 
for receptor occupancy analysis of brain α2C-adrenoceptors, and PET 
experiments in monkeys and humans indicated that tracer uptake 
into the caudate and putamen was reduced by interventions that 
increased synaptic noradrenaline concentrations in the brain [1-3]. This 
study aimed to confi rm the sensitivity of [11C]ORM-13070 binding to 
increased levels of synaptic noradrenaline.
Methods: PET imaging of the brain was performed with a 3D High 
Resolution Research Tomograph. Eight subjects underwent a control 
[11C]ORM-13070 PET scan and two PET scans after two diff erent 
noradrenaline challenges, i.e. a sub-anaesthetic infusion of ketamine 
and oral intake of atomoxetine combined with cold stimulation. Tracer 
uptake in the caudate nucleus and putamen was described with AUC 
values in scan time windows of 10-20 min and 5-30 min post injection, 
and quantifi ed with the ratio method. Voxel-based analysis was 
performed with average B/F images. Both challenges caused small but 
statistically signifi cant (10–20%, p < 0.05) reductions in tracer uptake in 
both target regions. Voxel-based analysis revealed signifi cant clusters 
in the dorsal putamen with both challenges. Ketamine was associated 
with signifi cant elevations in circulating noradrenaline and adrenaline 
levels, while the atomoxetine  + cold treatment was not. Strong 
experimental support was gained for the feasibility of [11C]ORM-13070 
PET imaging of brain noradrenergic neurotransmission.
Keywords Adrenoceptor, noradrenaline, positron emission 
tomography
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Opioid receptors (OR) are widely known as mediators of the analgesic 
eff ects of opioids and also contribute to the development of tolerance 
and dependence. Moreover, opioids are implicated in cell proliferation 
and survival. How opioids modulate these downstream signaling 
pathways is a research receiving a lot of attention. Our group aims 
to defi ne the signaling pathways through which opioid receptors 
participate in these physiological processes. Emphasis is given to 
unconventional interacting partners of the μ and δ-opioid receptors 
such as the Regulators of G protein signalling (RGS) proteins and 
STAT5B (Georgoussi et al. 2012). Evidence will be presented with which 
RGS proteins opioid receptors interact, how RGS members confer 
selectivity to receptors to choose a specifi c subset of G proteins, how 
activation of opioid receptors result in recruitment of RGS proteins to 
the plasma membrane and exert a diff erential modulatory eff ect in 
ERK1,2 phosphorylation, agonist-driven adenylyl cyclase inhibition and 
internalization of the opioid receptors (Papakonstantinou et al., 2015). 
Moreover evidence will be presented on how STAT5B associates with 
the δ-opioid receptor and forms selective pairs with selective Gα, Gβγ 
subunits and RGS proteins, and how activation of the δ-opioid receptor 
with selective agonists promotes a multi-component signaling 
complex involving the STAT5B transcription factor and other signaling 
intermediates to mediate neuronal survival and neurite outgrowth 
(Georganta et al., 2013). Understanding the mechanism that control 
OR signaling is important to address problems related to phenomena 
such as pain perception, tolerance and dependence that occur upon 
chronic opiate administration and defi ne whether disruption of such 
interactions may contribute to the development of novel therapeutic 
strategies.
Acknowledgements Supported by the EU “Normolife”-LSHC-
CT2006-037733 and the GSRT, Excellence II -3722, “NO-ALGOS”. Z.G 
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Autism spectrum disorders (ASD) are heterogeneous, heritable 
neurodevelopmental conditions, aff ecting ~0.5% of the population 
across cultures, with a ~4:1 male/female ratio. ASD are characterized 
by social interaction and communication defi cits, restricted interests, 
repetitive behaviors, and reduced cognitive fl exibility. Causes likely 
converge at the synapse, as shown by mutations of synaptic genes 
or mutations causing quantitative alterations in synaptic protein 
expression. Neuroligin4 (NLGN4X) mutations are among the most 
frequent causes of heritable ASD. But monogenetic forms altogether 
account for 1200 schizophrenic subjects and validated it in Asperger 
autists. We hypothesized that a coincidence of unfortunate normal 
variation in synaptic or synapse-regulating genes rather than mutations 
underlies most autistic phenotypes. We identifi ed ‘proautistic’ variants 
in synaptic genes, which in aggregate are associated with high autism 
severity. A transcranial magnetic stimulation study on respective 
individuals revealed enhanced glutamatergic and GABAergic activity. 
IPS-derived cortical neurons from these subjects are now functionally 
characterized.
Keywords Autism, synapse, ambra1
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Motor neuron disease (MND) is a neurodegenerative disease of mid-life, 
with average survival of 3-5 years after diagnosis. The only approved 
treatment, riluzole, is only moderately eff ective and so there is a great 
need for novel therapeutics. TAR DNA binding protein 43 (TDP-43) has 
held a particular centrality in MND research since its discovery as the 
principal protein component of the characteristic protein aggregates 
found in the disease. Subsequent work has investigated its role as 
an RNA-binding protein and regulator of approximately 3000 RNA 
transcripts. In the majority of disease cases, both familial and sporadic, 
normally nuclear TDP-43 is sequestered in the cytoplasm in protein 
aggregates. Using diff erentiated motor neuron-like cells (NSC-34) and 
primary motor neurons, we have treated cells with the disease-relevant 
ER stressor tunicamycin. Overnight treatment with a low concentration 
of tunicamycin resulted in the formation of aggregates immunoreactive 
for endogenous TDP-43, as visualised by immunocytochemistry 
and Western blotting of the RIPA-insoluble fraction. We have found 
that these aggregates do not co-stain for TIAR, a well-known marker 
of stress granules. However, using the oxidative stressor sodium 
arsenite, we are able to induce formation of stress granules, though 
they do not co-stain for TDP-43. The tunicamycin treatment also led 
to a moderate decrease in cell viability, as shown by MTT and Trypan 
Blue Exclusion assays. In this study, we have recapitulated a known 
pathological process (ER stress) of MND in vitro, which resulted in the 
formation of TDP-43 aggregates. The signalling pathways driving TDP-
43 aggregation are unknown, hence work detailing these mechanisms 
is likely to present wide scope for therapeutic intervention.
Keywords TDP-43, MND, aggregation
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Spinal and bulbar muscular atrophy (SBMA) and amyotrophic lateral 
sclerosis (ALS) are motoneuron diseases. A mutation in the androgen 
receptor (ARpolyQ) gene is responsible for SBMA. Mutations in the 
SOD1, in the TDP-43, in the FUS-TLS or in the C9ORF72 genes are 
responsible for familiar form of ALS. The mutated coded proteins misfold 
and aggregates. Effi  cient protein quality control (PQC) is required 
for the maintenance of physiological and soluble protein pool in 
aff ected motoneuron. The balance between autophagy and ubiquitin-
proteasome system (UPS) prevents protein aggregation and increases 
degradation of SBMA and ALS misfolded proteins. Dynein binds the co-
chaperone BAG3 and transports the mutant proteins at microtubule 
organization center where misfolded proteins interact, aggregate and 
can be degraded by autophagy. However, here misfolded proteins 
may blocks autophagy fl ux. In NSC34 cells, dynein is sequestered into 
ARpolyQ aggregates suggesting the role of dynein into aggregates 
formation process. Unexpectedly, the silencing of dynein heavy chain 
resulted in a drastic reduction of ARpolyQ retained in fi lter retardation 
assay (FRA). Moreover, dynein silencing drastically altered autophagic 
markers localization (LC3 and p62) by immunofl uorescence. Notably, 
treatment with a dynein inhibitor (EHNA) drastically reduced the 
retention of ARpolyQ, mutSOD1 and mutTDP43 aggregates in FRA, 
even when autophagy was inhibit with 3-MA. Conversely UPS blockage 
with MG132 counteracted the reduction induced by altered dynein 
transports. RTq-PCR on NSC34 cells treated with EHNA showed an 
increased BAG1:BAG3 ratio that can targeting the misfolded proteins 
to UPS. Moreover, in NSC34 cells, EHNA increased the degradation of 
proteasome reporter GFPu, while BAG1 overexpression reduced the 
level of aggregates retained in FTA. These data suggest that, when 
autophagy is overload, by misfolded proteins, dynein inhibition 
restores the physiological and soluble protein pool via UPS.
Keywords MNDs, PQC, dynein
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Diabetic retinopathy (DR) is a neovascular, infl ammatory and neuro-
degenerative disease. The neovascular component is treatable but no 
therapeutic agents are available for the other two components. Early 
changes in the diabetic retina include neuronal death of amacrine 
and retinal ganglion cells (RGC) (Barber et al., J Clin Invest, 1998), and 
elevated levels of infl ammatory mediators (Yoshimura et al., Plos One, 
2009). Nerve Growth factor (NGF) receptors, namely TrkA and p75NTR, 
are expressed in RGC. The TrkA receptor activates prosurvival, while 
p75NTR activates infl ammatory and apoptotic pathways (Mysona et 
al., Expert Rev Ophthalmol, 2014). Dehydroepiandrosterone (DHEA) 
binds to both receptors, mimicking NGF. It aff ords anti-apoptotic, 
neuroprotective and anti-infl ammatory eff ects in the retina (Kokona et 
al., Neuro-pharmacol, 2012, Straub et al., J Clin Endocrinol, 1998). The 
therapeutic use of DHEA is restricted due to its metabolic products. 
The main objective of this study was to investigate and compare the 
neuroprotective and anti-infl ammatory eff ects of DHEA and its spiro-
epoxy derivatives BNN27 and BNN20 (Calogeropoulou et al., J Med 
Chem, 2009) (not metabolized to estrogens and androgens), in the rat 
streptozotocin model of DR. BNN27, via TrkA activation, protected in a 
dose-dependent manner (2, 10, 50 mg/kg, ip) bNOS (brain nitric oxide 
synthetase) and TH (tyrosine hydroxylase) expressing amacrine cells 
and ganglion axons (NFL immunoreactivity) similar to DHEA’s actions, 
while BNN20 was less eff ective. BNN27 activated the TrkA prosurvival 
signaling pathway ERK1/2 kinase. It reduced the activation of SAPK/
JNK kinase and the expression of p75NTR. BNN27 also increased the 
expression of anti-infl ammatory cytokines (IL10). These results suggest 
that NGF TrkA receptor is involved in the neuroprotective and anti-
infl ammatory eff ects of BNN27 and is a valuable target via which 
BNN27 could aff ord effi  cacious therapeutics for the treatment of DR.
Acknowledgements Funded by GGET. ARISTEIAII.
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Perinatal complications are a serious clinical problem, in particular 
hypoxic-ischemic (HI) episodes, caused by birth asphyxia or uterine 
and fetal blood fl ow interruption. HI corresponds to 23% of neonatal 
deaths, being one of the top 20 leading causes of disease burden. 
Preconditioning (PC) is a stimulation below the injury threshold that 
activates endogenous protective mechanisms to prevent damage. 
Low doses of carbon monoxide (CO) play a benefi cial role through PC 
induction. Herein, CO cytoprotection was explored in distinct brain 
models. The used experimental models range from monoculture of 
astrocytes, co-cultures of neurons and astrocytes, to the whole organism 
with the rat model of perinatal ischemia. In primary cultures of astrocytic 
cells, CO not only impairs mitochondrial membrane permeabilization, 
by ANT glutathionylation, but also strengths mitochondrial oxidative 
metabolism, by modulating COX activity, increasing mitochondrial 
biogenesis and ATP amounts. Also, CO reinforces astrocytes-neurons 
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communication towards neuronal survival. Purinergic molecules are 
the main mediators for this non-cell autonomous eff ect. Our results 
seem to indicate that the main pathway involved includes ATP release 
from astrocytes, its metabolization and A2A receptor binding to initiate 
protective mechanisms within the neurons. Rat pups were exposed 
to CO before hypoxia-ischemia induction (Vannucci model). 24  h 
after HI the brains were collected for cell death and tissue protection 
assessment (histological and immunohistochemical analysis). It was 
found limited apoptosis in hippocampus following cerebral ischemia: 
lower cytochrome c release and caspase-3 activation yielding an 
increased Bcl-2 expression. Altogether, one can conclude that there is 
not just a unique pathway for the CO-induced endogenous protection, 
brain tolerance is the result of a complex cellular change in response to 
injury. Indeed, CO regulates cell death pathways and modulates cellular 
metabolism.
Keywords Carbon monoxide, preconditioning, ischemia
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Severe hypobaric hypoxia (180 mm Hg) is a harmful stimulus that induces 
structural and functional injures of susceptible brain neurons in the 
neocortex and hippocampus. In contrast, moderate hypobaric hypoxia 
(360  mm  Hg) activates endogenous cellular defensive mechanisms. 
The rate of neuroprotection aff orded by the mild hypoxia depends on 
the quantity of hypoxic sessions. In particular, preconditioning (pre-
exposure) by three trials of mild hypoxia protects from deleterious 
eff ects of subsequent severe hypoxia whereas preconditioning with 
one mild hypoxic trial does not. The molecular mechanisms induced by 
mild hypoxic preconditioning are unclear. Pro-survival proteins, such as 
neurotrophic factor BDNF and anti-apoptotic factor Bcl-2 are supposed 
to be involved in this process. In the present study, the eff ects of three-
trial and one-trial hypoxic preconditioning on the expression of pro-
survival proteins BDNF and Bcl-2 as well as their up-stream activator 
pCREB, have been studied in the neocortex and hippocampus of 
rats. As revealed by quantitative immunocytochemistry, the severe 
hypobaric hypoxia didn’t aff ect or down-regulated the neuronal 
levels of pCREB, BDNF and Bcl-2 at 3–24 h after the exposure. The one-
trial preconditioning did not change this eff ect of severe hypoxia. In 
contrast, preconditioning by three trials of mild hypoxia (360 Torr, 2 h, 
24 h intervals, 3 times) signifi cantly enhanced the pCREB, BDNF and Bcl-
2 neuronal expression in response to severe hypoxic challenge. Three-
trial mild hypoxia alone also up-regulated the expression of molecular 
factors examined in the neocortex and hippocampus at 24 h whereas 
one trial of the mild hypoxia did not. The results of the present study 
indicate that development of the neuronal hypoxic tolerance induced 
by the three-trial, in contrast to one-trial, mild hypoxic preconditioning 
is apparently largely associated with the activation of CREB, as well as 
BDNF and Bcl-2 overexpression.
Keywords Hypoxic preconditioning, brain hypoxic tolerance, pCREB
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Ankrd11 is a potential transcriptional regulator that is implicated 
in cognitive dysfunction and ASD, but has no known function in the 
brain. We show that Ankrd11 is expressed in the embryonic cortex, 
and that when it was knocked-down in murine cortical precursors this 
caused decreased proliferation, reduced neurogenesis, and aberrant 
neuronal positioning in developing cortex. Knockdown of Ankrd11 in 
human forebrain neural precursors phenocopied Ankrd11 knockdown 
in murine neural precursors. Decreased proliferation of embryonic 
and adult neural precursors and neuronal mispositioning were also 
observed in Yoda mice carrying a point mutation in the histone 
deacetylase (HDAC)-binding domain of Ankrd11. Yoda mice also 
displayed ASD-like behavioural abnormalities. Consistent with a role for 
Ankrd11 in histone acetylation, Ankrd11 was associated with chromatin 
and co-localized with HDAC3. Also, expression and histone acetylation 
of Ankrd11 target genes were altered in Yoda neural precursors. Finally, 
the Ankrd11 knockdown-mediated decrease in precursor proliferation 
was rescued by inhibiting histone acetyltransferase activity or 
expressing HDAC3. Thus, Ankrd11 is a crucial epigenetic regulator 
of neural development that regulates histone acetylation and gene 
expression, thereby providing a likely explanation for its association 
with cognitive dysfunction and ASD.
Keywords Chromatin, stem cells, brain development
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Endocannabinoids (eCBs) are bioactive lipids which primarily infl uence 
synaptic communication in the nervous system. They are synthesized 
by neurons but also by microglia, especially under infl ammation. To 
exert their function, eCBs travel across the intercellular space. However, 
how eCBs move extracellularly remains obscure. Our recent evidence 
indicates that reactive microglia release extracellular vesicles (EVs), 
which may represent an ideal vehicle for the transport of hydrophobic 
eCBs. Hence, in this study we investigated whether microglial EVs carry 
eCBs and may infl uence neurotransmission. First we analyzed the eCB 
content of EVs and found a clear enrichment of anandamide (AEA) in EVs 
relative to parental microglia. This analysis revealed higher AEA levels 
in EVs shed from the plasma membrane (microvesicles), compared to 
those which originate from the endocytic compartment (exosomes). 
To bioassay the activity of vesicular AEA, we used patch clamp analysis 
of miniature inhibitory post-synaptic currents (mIPSC) on hippocampal 
neurons in vitro. Exposure of neurons to microvesicles (MVs) induced 
a signifi cant decrease in mIPSC frequency, mimicking the action of 
CB1R agonists. The involvement of vesicular AEA in this phenomenon 
was inferred from the ability of the CB1R antagonist SR141716A to 
block the reduction of mIPSC frequency evoked by MVs. Western blot 
analysis showed that MVs induces an increase in ERK phosphorylation, 
which was completely inhibited by SR141716A. This indicate that CB1R 
activation by AEA-storing MVs translates into downstream signaling. 
Finally, consistent with a surface localization of AEA, MVs membranes 
maintained their capability to decrease mIPSC frequency. Overall, this 
study shows that microglial MVs carry AEA on their surface to stimulate 
CB1R on target GABAergic neurons thus playing a crucial role in the 
modulation of inhibitory transmission.
Keywords Endocannabinoids, extracellular vesicles, microglia-neuron 
signaling
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Peripheral nerve injuries are an important part of everyday medical 
practice since there are reported over 600,000 cases in Europe and 
in the United States annually [1]. Many of such nerve injures cause 
gaps between nerve stumps. Without intervention, they can lead 
to the formation of a stump neuroma, what can result in functional 
impairment of the nerve fi ber. The current approaches to regeneration 
of damaged peripheral nerves include: autografting, allografting, and, 
last but not least, the implantation of polymeric tubes and conduits 
between nerve stumps. Nerve autografting is considered as the “gold 
standard” technique for the repair of peripheral nerve discontinuities, 
but it has a number of limitations, such as the requirement for the 
second surgical procedure to harvest the graft tissue, the donor site 
morbidity, additional injuries and scarring as well as the increased 
recovery time. Allografts (e.g., cadaver nerve grafts) and xenografts 
(e.g. animal nerve grafts) can be an alternative to autografts, but their 
main drawback lies in the high possibility of an undesirable immune 
response. The most promising materials for peripheral nerve conduits 
preparation are natural biopolymers. They are obtained from natural 
sources, exhibit similar properties to the tissues they are replacing 
and reveal good cell adhesion. Furthermore, they tend to accelerate 
regeneration processes due to specifi c chemical interactions within 
the human body, e.g. with extracellular matrix (ECM) molecules. The 
purpose of our study is to create a conduit with properties that will 
mimic the ones of the extracellular matrix of the peripheral nervous 
system. Our focus is put on natural polymers, especially chitosan. 
In addition, we use chemotactic factors which exhibit properties 
benefi cial in regeneration of the peripheral nervous tissue.
Keywords Biomaterials, hydrogel, nerve regeneration
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Ginkgo biloba extract is a neuroactive agent that is widely used for 
correction of age-associated impairment of memory, attention defi cit 
and other cognitive functions. It has been shown that ginkgolides and 
bilobalides, Ginkgo biloba extract components, are potent blockers of 
glycine receptors [1,2]. However, the eff ect of ginkgolic acid, the other 
Ginkgo biloba extract constituent, on ligand-gated ion channels was 
not investigated. In the present study, using patch-clamp technique 
and transient transfection of diff erent subunits in CHO cells we have 
shown that glycine receptors (GlyRs) are modulated by ginkgolic acid 
in a subunit-specifi c manner. After pre-application of ginkgolic acid 
(0.5–2  min), glycine-induced currents mediated by α1 GlyRs were 
strongly potentiated, while currents mediated by α2 GlyRs exhibited 
weak inhibition. There was no signifi cant eff ect of ginkgolic acid on 
amplitudes of currents mediated by α3 GlyRs or on GABAARs composed 
of 1α/1β/2γ subunits. In order to further investigate subunit-specifi c 
eff ect of ginkgolic acid we have focused on possible interaction sites for 
this compound inside diff erent GlyR domains. We found that mutation 
of three residues (T59A/A261G/A303S) in α2 subunit can convert 
the inhibitory action of ginkgolic acid into potentiation. Indeed, 
application of ginkgolic acid to cells expressing α2 T59A/A261G/A303S 
subunits resulted in an increase of responses to low concentrations 
of glycine and abolishment of the inhibitory eff ect, typical for wild 
type α2 GlyR. Our results suggest that (i)  ginkgolic acid selectively 
enhances the function of α1 GlyRs and attenuates the function of α2 
GlyRs, (ii) mutation of α2 subunit converts eff ect of ginkgolic acid from 
inhibition to potentiation.
Keywords Glycine receptor, ginkgolic acid, patch-clamp
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Iron oxide nanoparticles (IONPs) are frequently used for biomedical 
applications including magnetic resonance imaging, drug delivery or 
tumor treatment by hyperthermia. Since IONPs can reach the brain 
from periphery or are directly applied into the brain, the investigation 
of potential adverse eff ects of IONPs on properties and functions of the 
diff erent types of brain cells is an important task. In order to directly 
compare diff erent types of brain cells concerning the uptake and 
toxicity of IONPs, we synthesized fl uorescent IONPs and characterized 
these BODIPY-labeled particles regarding their physicochemical 
properties. In the medium used for the cell studies, these particles 
had a hydrodynamic diameter of around 158 ± 28 nm and a negative 
surface charge with a zeta-potential of –10 ± 2 mV. Exposure of primary 
cultures of rat astrocytes, neurons and microglial cells revealed that 
among these cell types, microglial cells accumulated IONPs most 
rapidly. However, microglial cells were also most vulnerable towards 
acute IONP-induced stress while astrocytes and neurons were not 
acutely damaged by IONPs. In microglial cells, but not in astrocytes 
or neurons, IONPs were found to be localized in lysosomes and large 
amounts of reactive oxygen species (ROS) were observed after IONP-
exposure. The IONP-induced toxicity in microglial cells was prevented 
by neutralizing lysosomes or by chelation of intracellular ferrous iron 
ions, suggesting that the toxic potential of IONPs in microglia involves 
rapid particle uptake, liberation of ferrous iron from the internalized 
IONPs in the acidic lysosomal compartment and iron-catalyzed ROS 
formation. These data suggest that also in brain IONPs may harm 
microglial cells and compromise microglial functions.
Keywords Toxicity, protection, nanoparticles
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Regulated traffi  cking of mitochondria in neurons is essential for 
providing ATP at the correct spatial location to power neural function 
and computation, and for providing calcium buff ering at sites of 
calcium entry or release. Indeed the regulation of mitochondrial distri-
bution, morphology and function are proposed to play an important 
role in neuronal development and survival but the regulatory 
mechanisms remain unclear. Miro family proteins (Miro1 and Miro2 
in mammals) contain a transmembrane domain locating them to the 
outer mitochondrial membrane, along with two GTPase domains and 
two calcium-sensing EF-hand domains that face into the cytosol, and 
play a key role in regulating mitochondrial transport. Miro proteins 
mediate mitochondrial traffi  cking in neurons by linking mitochondria 
to kinesin and dynein motor proteins for their transport in axons and 
dendrites. Miro proteins are also targets for the Parkinson’s Disease 
associated PINK1/Parkin mitophagy pathway and are therefore 
implicated in altered mitochondrial dynamics during mitophagy. Here 
I will present our recent results on the role played by Miro proteins in 
regulating mitochondrial traffi  cking and quality control. The role that 
Miro-mediated control of mitochondrial traffi  cking and turnover plays 
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in regulating neuronal development, function and pathology will also 
be explored.
Keywords Mitochondria, mitophagy, parkinson’s
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Mitochondrial fusion-fi ssion dynamics play a crucial role in many 
important cell processes. These dynamics control mitochondrial 
morphology, which in turn infl uences several important mitochondrial 
properties including mitochondrial bioenergetics and quality control, 
and they appear to be aff ected in several neurodegenerative diseases. 
The molecular machineries behind mitochondrial fusion and fi ssion 
events are relatively well known. The regulation of fusion and fi ssion 
events beyond the molecular machinery involved is less clear, fusion 
and fi ssion are not random occurrences but form a cycle whereby 
fi ssion typically follows fusion. Mitochondrial fi ssion machinery may 
somehow sense mitochondrial length and become active when the 
mitochondrion is oversized and cease when mitochondria are smaller. In 
contrast, mitochondrial fusion events depend heavily on mitochondrial 
traffi  cking. Fusion only takes place when two mitochondria meet and 
motile mitochondria will be more likely to encounter one another. 
In cultured cortical neurons, for example, only one in every 14th 
contact between mitochondria results in fusion. The purpose of this 
presentation is to provide insight into the complex crosstalk between 
diff erent processes involved in mitochondrial fusion-fi ssion dynamics 
and to discuss the potential physiological purpose of mitochondrial 
fusion and fi ssion.
Keywords Mitochondrial dynamics, neurons, mitophagy
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Mitophagy specifi cally describes autophagy of damaged or dys-
functional mitochondria and occurs in programmed cell death 
when mitochondria fragment and remodel their cristae. Cellular 
bio energetics is entwined with mitochondrial dynamics, and 
mito chondrial insults, including depolarization and inhibition of 
electron transport chain, trigger mitochondrial fragmentation. 
Here we investigated mitophagy in neurons during manipulation 
of mitochondrial bioenergetics. Dysfunction of mitochondria was 
induced by pharmacological inhibition of respiratory chain complexes 
I-V (rotenone, 3-nitropropionic acid, antimycin A, KCN & oligomycin, 
respectively) in primary cultures of cerebellar granule cells. The 
extent of bioenergetic failure was determined by measuring [ATP], 
depolarization of mitochondrial membrane potential and decrease in 
oxygen consumption rate in the Seahorse XF24. All stressors produced 
mitochondrial dysfunction as shown by concentration- and time-
dependent decline in [ATP] over 4–24 h. Complexes I, III or IV showed 
rapid loss of mitochondrial membrane potential and decreases in 
oxygen consumption rate over 4–24 h. Autophagolysosomal fl ux was 
increased as shown by increased LC3-II and labelling of acidic vacuoles 
with monodansylcadaverine. Immunocytochemistry for PINK1 showed 
translocation of PINK1 from cytoplasm to mitochondria after injury, 
indicating likely involvement of mitophagy during bioenergetic 
dysfunction. Transfection of fl uorescent pH-biosensor Rosella (Rosado 
CJ, et al. Autophagy. 2008;4:205) targeting mitochondria indicated 
the pH of the mitochondrial location dropped with the inhibition of 
complex I and II, implying acidifi cation of mitochondria, presumably 
in acidic vesicles undergoing mitophagy. Dieback of neuronal arbor 
observed here paralleled that seen with a GFP-plasmid. Together these 
data indicate that bioenergetic dysfunction produces mitophagy in 
primary neurons and is likely to be involved in neuronal dynamics.
Keywords Mitophagy, PINK1, autophagolysosome
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The genes encoding the E3 ubiquitin protein ligase Parkin (PARK2) and 
the mitochondrial serine/threonine kinase PINK1 (PARK6) are mutated 
in clinically similar, autosomal recessive early onset Parkinson’s disease 
(PD) forms. Over the past ten years, a number of studies in diff erent 
model systems have demonstrated that PINK1 and Parkin regulate 
jointly several processes relevant to maintenance of mitochondrial 
quality, including mitochondrial traffi  cking and dynamics, mitophagy 
and biogenesis. By using a combination of approaches of cell 
biology, confocal imaging and biochemistry in diff erent cell models, 
we recently showed that loss of protein import effi  ciency triggers 
recruitment of Parkin by PINK1 in proximity of the translocase of outer 
mitochondrial membrane (TOM). We provided evidence that the 
degradation of specifi c TOM subunits plays a key role in initiating the 
autophagic degradation of damaged mitochondria. We also showed 
that PINK1 and Parkin interact with the TOM machinery on polarized 
mitochondria. Our results suggests that this interaction modulates 
the import of the multifunctional mitochondrion-protective matrix 
enzyme 17beta-hydroxysteroid dehydrogenase 10, which is depleted 
in Parkin-defi cient mice and Parkinson’s disease patients. Electron 
and confocal microscopy, and calcium imaging approaches used to 
characterize the endoplasmic reticulum (ER)-mitochondria interface, 
a compartment previously linked to neurodegenerative processes, 
revealed enhanced juxtaposition between these organelles, associated 
with increased ER-to-mitochondria calcium transfer in cells from Parkin-
defi cient mice and patients with PARK2 mutations. Our current work 
aims at investigating the relevance of mitochondrial quality control 
mechanisms regulated by PINK1 and Parkin in diff erent cell types of the 
central nervous system, to evaluate the contribution of each of them to 
the physiopathology of autosomal recessive Parkinson’s disease.
Keywords Parkinson’s disease, mitophagy, ER/mitochondria interface
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We have originally discovered activity-dependent neuroprotective 
protein (ADNP) as a major regulatory gene, a component of the SWI/
SNF chromatin remodeling complex, essential for brain formation. 
Others found ADNP as a most frequent autism spectrum disorder (ASD)-
associated gene. Furthermore, ADNP is the only protein signifi cantly 
decreasing in the serum of Alzheimer’s disease (AD) patients. Our most 
recent results revealed sex-related learning/memory diff erences in 
mice, refl ecting hippocampal expression changes in ADNP and ADNP-
controlled AD/ASD risk genes1. Hippocampal ADNP transcript content 
was doubled in male vs. female mice, with females showing equal 
expression to ADNP+/– males and no signifi cant genotype-associated 
reduction. Increased male ADNP expression was replicated in human 
postmortem hippocampal samples. The hippocampal transcript 
for ApoE (the major risk gene for AD) was doubled in female mice 
compared with males, and further doubled in the ADNP+/– females, 
contrasting a decrease in young ADNP+/– males. ADNP regulates 
>400 genes during embryonic development, with ApoE being a major 
target. Other AD related proteins regulated by ADNP include tau (with 
pathological tau constituting the neurofi brillary tangles and with 
AD being the major tauopathy). Furthermore, ADNP associates with 
microtubule end binding proteins, controlling dendritic spine density, 
which is compromised in AD and ASD. Previously, overexpression 
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of the eukaryotic translation initiation factor 4E (eIF4E) led to ASD-
like phenotype in mice and we have shown that hippocampal eIF4E 
expression was specifi cally increased in young ADNP+/– male mice. 
Understanding ADNP expression, positioned as a master regulator of 
key ASD and AD risk genes, introduces a novel concept of hippocampal 
gene-regulated sexual dimorphism toward gender-based biology and 
therapeutics.
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Neurotrophin brain-derived neurotrophic factor (BDNF) is a growth 
factor that has important roles in the development and functioning 
of nervous system by promoting the survival, diff erentiation and 
synaptic plasticity of specifi c neuronal populations. Modifi ability of 
neuronal connectivity by formation of new synapses, and alteration 
of the strength and stability of existing synapses, is regarded as the 
main cellular basis for memory and long-term behavioral adaptations. 
The gene encoding BDNF is considered to be one of the master genes 
of synaptic plasticity. BDNF has also received particular interest for 
its deregulation in nervous system disorders. Decreases of BDNF 
and its receptor TrkB levels and activity are accompanied by and are 
believed to lead to several pathologies, particularly nervous system 
diseases like neurodegenerative, psychiatric and cognitive diseases. 
Therefore knowledge about the regulatory mechanisms of BDNF gene 
is important both for understanding of nervous system function and 
for fi nding new drug targets. Results of our studies on the molecular 
mechanisms of neuronal activity-regulated expression of BDNF gene in 
the nervous system will be presented and discussed.
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Hypoxic preconditioning is a pre-exposure to the repetitive mild 
hypoxia which results in development of brain hypoxic/ischemic 
tolerance and cross-tolerance to injurious factors of another nature. The 
endogenous defense processes mobilized by hypoxic preconditioning 
and resulting in formation of brain tolerance are based on evolutionary 
acquired gene-determined mechanisms of neuroprotection and 
adaptation. Key event is an activation of pro-adaptive transcriptional 
factors HIF-1, CREB, NF-kB, c-Fos, NGFI-A and down-stream expression 
of their target genes in vulnerable brain neurons. An important role can 
thus be suggested for the epigenetic regulation of gene expression, in 
particular, acetylation of core nucleosome histones leading to changes 
in chromatin structure which ensure access of the transcriptional factors 
activated by the preconditioning to the promoters of target genes. It 
has been shown that hypoxic preconditioning considerably increases 
an acetylation status of all histones and, particularly, H3 in the neurons 
of rat hippocampus and neocortex, whereas injurious severe hypoxia 
causes global repression of histone acetylation. Diverse eff ects of the 
severe hypoxia and mild hypoxic preconditioning on the methylation 
of DNA and histones have also been observed. The complex of the 
epigenetic modifi cations induced by the hypoxic preconditioning is 
attributed to the relaxed DNA which becomes available for activation of 
gene expression by pro-adaptive transcriptional factors up-regulated 
by the preconditioning.
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Understanding the mechanisms regulating gene expression in 
the course of development and adaptation of the organism to the 
permanently changing environment and in the case of pathology is 
fundamentally important. Special attention in recent years has been 
paid to the processes of epigenetic regulation of neuronal genes 
involving chromatin modifi cations at the level of DNA methylation 
and histone acetylation. In these processes an important role belongs 
to the histone deacetylases (HDAC) which control gene silencing. 
Recently it was shown that the amyloid precursor protein (APP) and 
its intracellular domain (AICD) participate in regulation of expression 
of a number of neuronal genes, including those involved in amyloid 
metabolism and clearance. The list of APP-regulated genes includes the 
major amyloid-degrading enzyme neprilysin (NEP), a transport protein 
transthyretin (TTR), aquaporin and others. Our studies strongly indicate 
that AICD regulation of NEP and TTR is APP isoform-dependent and 
cell-type specifi c. In this process AICD competes for gene regulation 
with HDACs and treatment of cells or animals with HDAC inhibitors 
such as valproic acid results in up-regulation of NEP and TTR mRNA 
and protein levels and increased NEP activity leading to a reduction in 
total cellular amyloid (Aβ) peptide levels. Regulation of other proteins, 
e.g. acetylcholinesterase, does not involve AICD but requires full length 
APP molecules. APP overexpression in neuronal cells was also shown 
to aff ect the levels of HDAC gene products which might explain its 
role in gene regulation. Further studies of the APP interactome are 
important for better understanding of its role in brain development 
and functioning and for designing the drugs protecting the brain 
against neurodegeneration, in particular Alzheimer’s disease.
Acknowledgements Supported by RFBR (13-04-00388), Program of 
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The transcription factor Nrf2 and its downstream target heme 
oxygenase-1 (HO-1) are ubiquitous protective systems against 
oxidative stress, infl ammation and tissue injury. The products of HO-1 
enzymatic activity, biliverdin and carbon monoxide (CO), possess 
interesting anti-oxidant and anti-infl ammatory properties suggesting 
that exploitation of this pathway as a target for drug discovery may 
off er therapeutic avenues in a variety of disorders [1]. In this context 
we have developed carbon monoxide-releasing molecules (CO-RMs), a 
class of compounds that deliver CO in a controlled fashion and exert a 
variety of pharmacological eff ects [2]. Data will be presented showing 
that CO-RMs modulate neuroinfl ammation and neuroprotection in 
vitro and in vivo. In BV2 microglia cells challenged with thrombin and 
interferon gamma, CO-RMs reduced the production of infl ammatory 
mediators both in normoxic and hypoxic conditions. Similarly, in a 
rat model of collagenase-induced intracerebral hemorrhage, CO-RMs 
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modulated microglia activation and the production of TNF-α while 
partially protecting against brain damage [3]. The mechanism(s) by 
which CO liberated from CO-RMs exert protection remains elusive. 
However, our laboratory has recently produced fi ndings in BV2 
microglia pointing to mitochondria as a plausible target for the anti-
infl ammatory action of CO. Studies are also currently ongoing on the 
synthesis and characterization of novel hybrid molecules that potently 
activate Nrf2 and simultaneously release CO in order to maximize the 
anti-infl ammatory eff ects of the HO-1 pathway [4].
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The endogenously produced gasotransmitter carbon monoxide (CO) 
has been studied as a factor involved in cytoprotection, homeostasis 
and anti-infl ammation. Small amounts of reactive oxygen species (ROS) 
are described as signaling factors in CO’s biological mode of action. 
Mitochondria are the main source of ROS and are also key organelles 
in orchestrating cell function: metabolism, cell death control and 
redox signaling. Astrocytes are most abundant glial cells and essential 
for neuronal function, namely metabolic and physical support, 
expression of neurotransmitters and promotion of neuroprotection. 
In this work it is shown that CO prevents astrocytic cell death and 
improves cell metabolism by targeting mitochondria, and some of the 
underlying molecular mechanism are disclosed. CO directly targets 
non-synaptic mitochondria and inhibits their mitochondrial membrane 
permeabilization, by preventing mitochondrial swelling, depolarization 
and inner membrane permeabilization. Thus, CO limits the release 
of cytochrome c into the cytosol and the activation of apoptotic 
cascade in astrocytes. All these events are ROS-dependent and involve 
glutathionylation of adenine nucleotide translocator (ANT), whose 
activity is ATP/ADP transport through mitochondrial inner membrane. 
In addition, low amounts of exogenous CO increase ATP production by 
improving oxidative metabolism. Mitochondrial population and specifi c 
cytochrome c oxidase activity are higher upon CO treatment. The CO-
induced metabolic improvement is dependent on Bcl-2 expression. 
Dysfunctional mitochondrial can be eliminated by mitophagy, which is 
a crucial process for maintaining their function and quality control. In 
astrocytes, CO promotes mitophagy at 1 h of treatment, while following 
24 h mitochondrial population is back to basal levels, indicating that CO 
contributes to mitochondrial turnover. Furthermore, CO limits astrocytic 
cell death in an autophagic dependent manner.
Keywords Carbon monoxide, astrocytes, mitochondria
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Stopping the succession of events that lead to development of 
Parkinson’s disease (PD) is a principal challenge that requires a brain 
protective approach in early diagnosed patients. Although PD 
ethiopathology may not have a single causative factor, information 
from sporadic and familial cases together with chemical and genetic 
animal models strongly suggests that low-grade chronic infl ammation 
and oxidative stress play a critical role. Our team is studying the 
relevance of the transcription factor NRF2 (Nuclear factor (erythroid-
derived 2)-like 2), a master regulator of oxidant and infl ammatory 
defense, as a new therapeutic target in PD. The pro-infl ammatory 
activation of microglia and astroglia in response to LPS, MPTP and 
human α-synuclein over-expression is exacerbated in Nrf2-defi cient 
mice, thus demonstrating an immunomodulatory role of this protein. 
In PD patients, some evidence gathered from epidemiological, genetic 
and anatomopathologic studies also support a protective role of NRF2. 
Several compounds activate NRF2 and provide an immunomodulator 
and cytoprotective response in preclinical animal models of PD. 
At this time a crucial point to translate these promising results to 
the clinic is the discovery of a drug with good pharmacokinetics 
and pharmacodynamics that fulfi ll criteria of safety, tolerability and 
effi  cacy. The use of repurposing drugs, such as dimethyl fumarate used 
nowadays for treatment of remitting relapsing multiple sclerosis, may 
provide excellent candidates.
Keywords Neuroinfl ammation, Nrf2, Parkinson’s disease
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Carbon monoxide (CO) is a gaseous second messenger produced 
when heme oxygenase (HO) enzymes catabolize heme. We have 
demonstrated that CO can be therapeutic in ischemia-reperfusion 
brain injury; however, it is unclear whether CO can also off er protection 
in permanent ischemic stroke or what mechanism underlies the eff ect. 
HO1 neuroprotection is shown to be regulated by Nrf2; therefore, 
we investigated whether CO might partially exert neuroprotection 
by modulating the Nrf2 pathway. To evaluate potential protective 
eff ects of CO, we exposed wildtype and Nrf2–/– mice to 250 ppm CO 
or control air for 18  h immediately after permanent middle cerebral 
artery occlusion. Infarct volume and neurological defi cits were 
assessed on day 7. Molecular mechanisms of Nrf2 pathway activation 
by CO were also investigated. Mice exposed to CO after permanent 
ischemia had 29.6  ±  12.6% less brain damage than did controls at 
7 days. Additionally, 18 h CO treatment led to Nrf2 dissociation from 
Keap1, nuclear translocation, increased binding activity of Nrf2 to HO1 
antioxidant response elements, and elevated HO1 expression 6–48 h 
after CO exposure. The CO neuroprotection was essentially completely 
abolished in Nrf2–/– mice. Low-concentration of exogenous CO 
represents a neuroprotective agent for stroke combination treatment 
and its benefi cial eff ect would be at least partially mediated by 
activation of the endogenous Nrf2 pathway.
Keywords Medical gas, neuroprotection, Nrf2-regulated protein, stroke
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Myelin is a membrane characterized by high lipid content to facilitate 
impulse propagation. Changes in myelin fatty acid (FA) composition 
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have been associated with peripheral neuropathy [1], but the specifi c 
role of peripheral nerve FA synthesis in myelin formation and function 
is poorly understood. We explored the extent to which lack of the key 
regulator of FA synthesis as Sterol Regulatory Element Binding Factor-
1c (Srebf-1c) could result in the development of peripheral neuropathy. 
We found that Srebf-1c null mice display a neuropathic phenotype 
consisting in hypermyelinated small caliber fi bers, the result of changes 
in myelin periodicity. Unexpectedly, transcriptomics and metabolomics 
revealed activation of peroxisome proliferator activated receptor α 
(Pparα) signaling in Srebf-1c null peripheral nerve as a result of increased 
levels of two distinct phosphatidylcholine-based Pparα ligands, PC-
C16:0/C18:1 and PC-C18:0/C18:1 [2,3]. Pparα is a nuclear receptor that 
directs uptake, utilization and catabolism of FAs [4]. As a consequence 
of abnormal local Pparα activation, Srebf-1c null peripheral nerve exhibit 
increased fatty acid utilization, a detrimental condition leading to 
peripheral neuropathy. Treatment with a Pparα antagonist rescues the 
neuropathy of Srebf-1c null mice. These fi ndings reveal the importance 
of FA synthesis to sustain peripheral nerve structure and function.
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Fertility critically depends by a small number of hypothalamic neurons 
secreting the neurohormone GnRH. During development GnRH neurons 
migrate from the nasal placode to the hypothalamus by following the 
migratory path formed by the vomeronasal axons. Developmental 
defects of this process can cause congenital GnRH defi ciency (GD), 
characterized by absent/delayed puberty and consequent infertility. 
The underlying mutated loci are for the majority of GD cases unknown, 
partially because of a poor understanding of the molecular mechanisms 
that control the development of these crucial neuroendocrine cells. 
Here we provide evidence of the importance of class 3 semaphorins 
and their receptors in this process. Specifi cally, I will explain how two 
diff erent semaphorins play distinct roles during the migration of GnRH 
neuron.s Thus, semaphorin3A aff ects the migration of GnRH neurons in 
the nasal compartment, via the co-receptors Neuropilin-1 and 2, whereas 
semaphorin3E via its receptor plexind1 controls the survival of GnRH 
neurons once positioned in the hypothalamus. Accordingly, disrupted 
semaphorin signalling may be involved in the aethiopathogenesis of 
genetic diseases characterized by GnRH defi ciency.
Keywords GnRH neuron, semaphorin, migration
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We analyzed the pathological consequences of abnormal Wnt/β-
catenin signaling in endothelial cells of brain vessels using a murine 
model of Cerebral Cavernous Malformation (CCM) disease that 
develops after endothelial-cell-selective ablation of the CCM3 gene. We 
report increased transcription activity of β-catenin in CCM3-knockout 
endothelial cells in in-vitro and in-vivo models. Such activation is cell-
autonomous, independent of Wnt-receptor stimulation, does not 
induce canonical Wnt/β-catenin signaling and represents an early 
response to CCM3 ablation that initiates the expression of EndMT 
makers before the onset of Tgf-β/BMP signaling which is required for 
the progression of the pathology, as we have previously described. 
We also show that the NSAIDs sulindac sulfi de and sulindac sulfone, 
which attenuate β-catenin transcription activity, signifi cantly reduce 
the number and dimension of vascular lesions in the central nervous 
system of mice with endothelial cell CCM3 knockout. These NSAIDs 
thus represent pharmacological tools for inhibition of the formation 
of vascular lesions, particularly with a view to patients aff ected by the 
genetic variant of CCM, who continue to develop new malformations 
over time.
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Wnt signalling represents an ancient and highly versatile signalling 
system, which plays diverse critical roles in embryonic development. 
Sensory neurons of the dorsal root ganglia require Wnt signalling for 
initial cell fate determination as well as patterning and synapse formation 
over later development. Recent studies have functionally linked mis-
regulation of Wnt signalling to cancer, bone disorders and abnormal 
synaptic function in adult life. We will discuss a novel, functional role 
of Wnt signalling pathways in sensitization of peripheral adult sensory 
neurons in a pathophysiological context, and the underlying molecular 
mechanisms. Using an interdisciplinary approach, through diff erent 
technique spanning molecular, genetic, and behavioural experiment 
in vitro as well as in vivo pain models in mice, we show that Wnt3a 
is able to recruit diff erent Wnt-pathways, to alter pain sensitivity in a 
modality-specifi c manner, acting via intracellular kinases in peripheral 
nerves. We found evidence for an intriguing dichotomy of non-
canonical signalling pathways in mediating mechanical and thermal 
hypersensitivity. Indeed, while the calcium pathway is mainly involved 
in thermal hypersensitivity, mechanical hypersensitivity is driven by 
the planar cell polarity pathway. Interestingly we did not fi nd clear 
functional evidence for the canonical Wnt signalling pathway in Wnt3a-
induced sensitization of nociceptors. Finally, we will provides evidence 
for a translational potential for targeting peripheral Wnt signalling in 
tumour-nerve interactions and pathological pain hypersensitivity, 
paving the way for therapeutic interventions.
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Parkinson’s disease (PD) is a neurodegenerative disease characterized 
by the loss of midbrain dopamine (mDA) neurons. Clinical trials using 
human embryonic midbrain tissue for transplantation have provided 
proof of concept that cell replacement therapy (CRT) can lead to not 
only symptomatic relief, but also changes in the course of disease and 
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withdrawal of medication. Human pluripotent stem cells are currently 
regarded as the main candidate cell type for CRT because they are readily 
available, expandable, and can be standardized and diff erentiated 
into mDA neurons capable of inducing functional recovery in animal 
models of PD. However, protocols for mDA diff erentiation are still far 
from optimal and require further improvement. We previously found 
that members of the Wnt family of morphogens regulate multiple 
aspects of mDA neuron development [1]. Diff erent branches of the Wnt 
signaling pathway, such as Wnt/β-catenin, activated by Wnt1, and Wnt/
PCP, activated by Wnt5a, have been thought to regulate separate or 
opposing functions. However, we found that Wnt5a cooperates with 
Wnt1 to promote mDA neurogenesis and that Wnt1 cooperates with 
Wnt5a to promote the diff erentiation of postmitotic mDA neuroblasts 
[2]. We are currently applying this knowledge to improve protocols for 
the diff erentiation of human stem cells into mDA neurons suitable for 
transplantation and functional recovery in animal models for PD [3].
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WNT signaling in microglia and the glioma microenvironment Gunnar 
Schulte WNT signaling is important during embryonic development 
and organogenesis having specifi c roles in the development of the CNS 
such as regulation of neural tube formation, axon guidance and CNS 
stem cell regulation. Our work has recently established a role of WNT 
signaling in the regulation of the brain’s macrophages, the microglia 
and thus WNTs emerge as novel regulators of CNS infl ammatory 
responses. First of all, it appeared that b-catenin levels are elevated 
in microglia in Alzheimer disease (AD) brains as well as microglia cells 
in AD mouse models. Employing in vitro studies of primary mouse 
microglia isolated from newborn mouse pups indicated that both WNT-
3A and WNT-5A induce diverse signaling routes in microglia leading to 
diff erential proinfl ammatory modulation of the cells. Interestingly, the 
net eff ect of WNT stimulation on the infl ammatory potential of mouse 
microglia is context dependent. While WNTs increase infl ammatory 
markers when giving to microglia alone, they are able to act in an anti-
infl ammatory manner when microglia are activated by prestimulation 
with lipopolysaccharides. Our fi ndings thereby indicate that WNTs 
act on microglia as a homeostatic regulator, further underlined by 
yet unpublished data that suggest that WNT-5A is elevated in human 
glioma associated with a distinct infl ammatory signature of the tumor 
as well as a substantial invasion of microglia.
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The major focus of ALS research has recently moved to RNA control 
of motor neuron functions, as most of the newly identifi ed genes, 
that alone account for more than half of ALS familial cases, are clearly 
associated to RNA regulation. These include FUS and TDP43, two DNA/
RNA binding proteins with a role in the regulation of RNA transcription, 
splicing, transport and translation, and C9orf72, a gene that is marked 
by the presence, in carriers, of an highly expanded GGGGCC repeat that 
is believed to provide the mutant gene of an acquired, toxic feature 
by an RNA-dependent gain of function mechanism. Thus, RNA dys-
metabolism is likely to represent a central issue in ALS pathogenesis. 
Yet, whether a specifi c step of RNA processing is particularly aff ected in 
ALS motor neurons is unclear. We have recently obtained evidence that 
a prominent eff ect of FUS and C9orf72 expression is the induction of 
stress granules-associated translational repression. In this presentation 
I will discuss our recent work on the molecular mechanisms underlying 
these eff ects and their potential relevance in ALS pathogenesis.
Keywords ALS, RNA traffi  cking, stress granules
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TDP43 is a ubiquitously expressed prevalently nuclear protein involved 
in RNA splicing, RNA stability and miRNA processing. Amyotrophic 
lateral sclerosis (ALS), frontotemporal dementia (FTD) and inclusion 
body myopathy (IBM) are characterized by TDP43 being depleted 
from the nucleus and accumulating in cytoplasmic inclusions, which 
are the pathological hallmark of the disease – these diseases are also 
defi ned as “TDP43 proteinopathies”. Mutations in TDP43 have been 
found to be causative of a proportion of ALS cases reinforcing the 
primary importance of this molecule in disease pathogenesis. The 
pathogenic mechanism by which TDP43 acts is unclear, and both loss 
of nuclear function (LOF) and gain of function (GOF) mechanisms have 
been proposed. We here discuss how we used muscle tissue, which 
provides high quality RNA of patient disease tissue, to investigate the 
consequences of TDP43 mislocalization. Further, we characterize two 
novel mouse TDP43 mutant lines, carrying ENU-induced mutations 
in order to study the eff ects of TDP43 mutations expressed at 
physiological levels in the mammalian central nervous system. One 
mutation (deltaRNA) strongly reduces the RNA-binding capacity of the 
protein; the second mutation (C-TERM) is in the glycine-rich C-terminal 
domain where the majority of human pathogenic mutations are 
found. Our results underline the importance of studying models with 
physiological expression levels of TDP43 mutations and shed light on 
the diff erent eff ects on RNA metabolism caused by the TDP43 loss and 
gain of function.
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Proximal Spinal Muscular Atrophy (SMA) is caused by an insuffi  cient 
supply of the Survival of Motor Neurons (SMN) protein. It is charac-
terized by the selective degradation of the alpha motor neurons in 
the spinal cord. Analysis of the mouse model, which faithfully mimics 
the SMN insuffi  ciency and the motor neuron phenotype, shows 
that motor neuron degeneration starts in the axons, specifi cally at 
the neuromuscular junctions. SMN is a house-keeping factor that is 
necessary for the assembly of the seven-membered ring of Sm proteins 
around the spliceosomal snRNAs and that is therefore required for 
pre-mRNA splicing. Such a function cannot easily explain the selective 
motor neuron phenotype. It has been proposed that insuffi  cient 
supply of the SMN protein aff ects alternative splicing, especially of 
U11/U12-dependent introns, in mRNAs that are crucially required in 
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motor neurons. Details, however, remain elusive. In addition to the Sm 
proteins, there are the like-Sm (LSm) proteins that also form heptameric 
complexes and participate in various steps of mRNA metabolism. We 
have previously shown that one such LSm complex is involved in the 
transport of mRNAs to the neurites, especially the axons of motor 
neurons. mRNA transport and local protein synthesis is an important 
mechanism to bring about sudden changes in the proteome at distal 
regions of the cell. Here, we further explore the role of the LSm proteins 
in neuronal mRNA regulation and how this could be relevant for the 
SMA pathology. Interestingly, we fi nd that one such LSm protein is 
signifi cantly depleted in the SMA mouse model before the onset of the 
disease, possibly indicating a causal involvement.
Keywords SMA, mRNA regulation, Sm-like proteins
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A number of diff erent genes have been found mutated in patients with 
Amyotrophic Lateral Sclerosis (ALS). Several of these genes encode 
for proteins involved in multiple steps of RNA processing, suggesting 
that mRNA dys-metabolism has a role in the degeneration of motor 
neurons. This is the case also for FUS-linked ALS. FUS (Fused in Sarcoma) 
is a DNA/RNA binding proteins with an established, yet not completely 
clear, role in the regulation of RNA transcription, splicing, transport 
and translation. However, recent evidence indicates that (similarly to 
mutant ALS-linked SOD1) the toxic function of this protein may lie 
also in its propensity to aggregate and sequester other proteins, and/
or in its ability to induce mitochondrial damage and oxidative stress. 
In this presentation I will discuss our recent work on the molecular 
mechanisms underlying these eff ects and their potential relevance in 
the pathogenesis of ALS.
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Spinobulbar muscular atrophy (SBMA) and amyotrophic lateral sclerosis 
(ALS) are two related motorneuron diseases (MNDs), both characterized 
by the presence of inclusions o aggregates of proteinaceous materials. 
In SBMA, aggregates contain mutant androgen receptors (AR) with 
an elongated polyglutamine tract (ARpolyQ), while in ALS aggregates 
contain TDP43, ubiquilin, optineurin, etc. Exceptions are familial ALS 
(fALS) forms linked to superoxide dismutase 1 (SOD1) mutations, in 
which aggregates are composed of mutant SOD1. Protein aggregation 
occurs when a large excess of proteins with aberrant conformations 
(misfolding) in produced and poorly cleared from the cells. Neurons 
contains an effi  cient protein quality control (PQC) system, but this may 
be insuffi  cient to correctly remove misfolded proteins, especially during 
aging. The PQC system requires the activities of effi  cient chaperones 
and of the two major intracellular degradative systems: the ubiquitin-
proteasome (UPS) and the autophagic systems. When misfolded protein 
are recognized by chaperones, they can be removed via autophagy by 
their engulfment into autophagosomes which then fuseto lysosomes. 
We found that motoneurons may responds to misfolded species 
by activating the expression of a small HSP, HSPB8, which facilitate 
the clearance of misfolded species via autophagy, usually acting by 
restoring the proper autophagic fl ux, found altered in MNDs. HSPB8 
requires its co-chaperone BAG3. BAG3 binds the protein 14-3-3 and 
with this it interacts with dynein in a complex which also includes 
HSC70-CHIP. Dynein moves this large complex on the microtubules 
organization center where autophagosomes are assembled. Here, CHIP 
ubiquitinated misfolded protein substrates allowing their recognition 
by p62 and clearance from the motoneurons. Thus, together, the PQC 
and the HSPB8 proteins help to protect motoneurons from damages 
associated to the presence of aberrant protein species accumulating 
in aff ected cells.
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Pituitary adenylate cyclase activating polypeptide (PACAP) is a 
neuropeptide with diverse occurrence and functions. One of the most 
well-known eff ects of PACAP is its strong neuroprotective eff ect. In this 
presentation we give an insight into recently described neurochemical 
changes induced by PACAP or altered by PACAP the lack of it. In an 
invertebrate model for Parkinson’s disease we found that PACAP 
eff ectively counteracts the dopamine-decreasing eff ect of rotenone, a 
mitochondrial neurotoxin. Similarly, in a 6-hydroxydopamine-induced 
rat model of Parkinson’s disease, we found that PACAP eff ectively 
increases dopamine levels. Furthermore, our proteomics analysis 
shows that PACAP treatment also counteracts the 6-OHDA-induced 
decrease in PARK-7 protein, eff ective against oxidative stress. Studying 
the role of endogenous PACAP, we found that PACAP-defi cient mice 
show higher susceptibility to toxic agents causing degeneration of 
the substantia nigra dopaminergic neurons. Using proteomic analysis 
we revealed that the expression of numerous proteins is altered 
in the mesencephalon and striatum of knockout mice. Among the 
altered proteins, several are involved in metabolic processes, energy 
homeostasis, and structural integrity. ATP-synthase and tubulin beta-
2A were expressed more strongly in PACAP-knockout mice. In contrast, 
the expression of more peptides/proteins markedly decreased in 
knockout mice, like pyruvate kinase, fructose biphosphate aldolase-A, 
glutathione S-transferase, peptidyl propyl cis-trans isomerase-A, 
gamma enolase, beta-synuclein and aspartate amino transferase. 
The altered expression of these proteins might partially account for 
the decreased antioxidant, cytoprotective and detoxifying capacity 
of PACAP-defi cient mice. The described changes may provide further 
explanation for the neuroprotective potency of PACAP.
Acknowledgements OTKAK104984, Arimura Foundation, MTA-PTE 
Lendulet Program, KTIA_13_NAP-A-III/5, NAP-B.
Keywords PACAP, neuroprotection, proteomics
L57
Contribution of the galanin system to infl ammation
Barbara Kofl er1, Susanne Brunner1, Andreas Koller1, Silke Wiesmayr2, 
Felix Locker1, Roland Lang2, Balint Botz3, Àgnes Kemény3, Zsuzsanna Helyes3
1Laura Bassi Centre of Expertise THERAPEP, Research Program for Receptor 
Biochemistry and Tumor Metabolism, Department of Pediatrics, Paracelsus 
Medical University, Salzburg, Austria; 2Department of Pediatrics, Paracelsus 
Medical University, Salzburg, Austria; 3Department of Pharmacology and 
Pharmacotherapy, János Szentágothai Research Center and MTA NAP B Pain 
Research Group University of Pécs, Pécs, Hungary.
SpringerPlus 2015, 4(Suppl 1):L57
Neurogenic infl ammatory components mediated by peptidergic 
sensory nerves have a crucial impact on the symptoms of infl ammatory 
diseases. Galanin is a regulatory sensory neuropeptide, which was 
shown to attenuate neurogenic infl ammation, but our current 
understanding about its endogenous targets, and physiologic 
importance is incomplete. Among the endogenous receptors of 
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galanin (GAL1, GAL2, GAL3) we found GAL3 to be the most abundantly 
expressed on the vasculature and GAL2 on diff erent types of immune 
cells including polymorphonuclear neutrophils and natural killer cells. 
Therefore, we evaluated if galanin exerts direct or indirect eff ects on 
these immune cells. Our data revealed that galanin can be regarded as 
an immunomodulatory peptide as it can sensitize polymorphonuclear 
neutrophils and natural killer cells towards proinfl ammatory cytokines. 
Since there are only scarce in vivo data concerning the role of GAL3 
in infl ammatory disease conditions, we analysed its involvement in 
the K/BxN serum transfer model of autoimmune arthritis and the 
oxazolone-model of allergic contact dermatitis, employing GAL3 
gene-defi cient mice. After arthritis induction, GAL3-knockout mice 
demonstrated increased clinical disease severity and earlier hindlimb 
edema than wildtype mice. Vascular hyperpermeability was also 
elevated compared to wildytpes, but neutrophil myeloperoxidase 
activity and arthritic hyperalgesia were not signifi cantly diff erent. In 
contrast, disease severity, vascular, and immune components were not 
aff ected in allergic contact dermatitis in GAL3 knockouts in comparison 
with wildtypes. Our fi ndings suggest GAL3 activation as a substantial 
anti-infl ammatory pathway in neutrophil-dominated autoimmune 
arthritis, modulating the early neurogenic vascular hyperpermeability 
and consequent edema formation. However, the involvement of GAL3 
activation in the T-cell dependent allergic contact dermatitis remains 
unsupported.
Keywords Galanin, infl ammation, immune cells
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During cerebellar development, granule cell precursors are produced 
from a secondary germinative zone forming the external granule cell 
layer (EGL). Immature granule neurons from the inner part of the EGL 
then start a tangential migration followed by a centripetal inward radial 
migration across the molecular and Purkinje cell layers to reach their 
fi nal destination at the bottom of the forming internal granule cell layer 
(IGL). This complex migratory process is highly regulated and takes 
about 2 days in rodents and it is essential for the proper formation of 
the cortical layers forming the mature cerebellum. In the IGL, granule 
cells diff erentiate to establish functional excitatory synapses with 
GABAergic neurons including Purkinje, basket, stellate and Golgi cells, 
or die. Some neurotrophins and neurotransmitters have been shown to 
be involved in the control of cerebellar granule cell survival, migration 
and diff erentiation. Initially, when I started my carrier as a researcher, 
we used to claim that very few neuropeptides were produced in the 
cerebellum. Nevertheless, we now know that this was wrong as we 
have recently identifi ed by mass spectrometry over 70  peptides 
expressed in the cerebellum during development. Over the years, the 
involvement of some of these peptides such as somatostatin, PACAP 
or ODN, has been established in the control of cerebellar granule cell 
survival, migration and diff erentiation as will illustrate my presentation.
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Orexins A and B (hypocretins 1 and 2) are two closely related peptides 
produced mainly by hypothalamic neurons that project to numerous 
brain structures. Orexins exert their biological activity by binding to 
two subtypes of GPCR receptors, OX1R and OX2R. The orexin system 
has been shown to orchestrate multifaceted physiological functions, 
including vigilance and the sleep/wake cycle, energy homeostasis, 
endocrine, visceral functions and pathological states, such as narcolepsy 
and drug abuse [1]. In addition, a neuroprotective potential of orexin A 
has been recently demonstrated in rats using a model of focal cerebral 
ischemia [2]. In our studies we investigated eff ects of orexins on 
survival of cultured neurons from the rat cerebral cortex. Quantitative 
real-time PCR revealed the presence of OX1R and OX2R in cortical 
neurons. Orexins and [Ala11-D-Leu15]orexin B (a selective agonist of 
OX2R), used at 0.001-1 microM concentrations, markedly increased 
neuronal cells viability, an eff ect associated with an attenuation of 
caspase-3 activity. Comparable potency of the three peptides suggests 
a predominant role of OX2R in the studied phenomenon. Under 
conditions of chemical hypoxia, orexins potently increased neuronal 
viability and protected cortical neurons from oxidative stress. The pro-
survival eff ect of orexins was blocked by U0126 and 10-DEBC, inhibitors 
of MEKK and Akt, respectively. In addition, orexins A and B stimulated 
Akt and ERK1/2 in cortical neurons in a time- and concentration-
dependent manner. It is suggested that both Akt and ERK1/2 play an 
important role in the pro-survival eff ects of orexins in neurons.
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Dopamine receptors are G-protein-coupled receptors (GPCRs), which 
are involved in a wide variety of physiological processes. Abnormalities 
in dopaminergic signal transduction are associated with many 
diff erent diseases. Therefore, dopamine receptors are targets for 
variety of drugs involved in disorders like schizophrenia, Parkinson’s 
disease, depression and many others. In order to develop drugs with 
less side eff ects and better effi  cacy it is necessary to understand and 
characterize receptor-ligand interactions in further detail. In addition, 
measuring the on- and off -rates of diff erent ligands provides important 
information about the kinetic profi les of potential drug candidates. 
We have applied fl uorescence anisotropy (FA) assay to investigate 
kinetic properties and affi  nities of diff erent ligands for dopamine D1 
receptor. For that we have implemented budded baculoviruses as a 
source of recombinant protein (Veiksina et al., 2014). As a result, we 
have seen that fl uorescent ligand Bodipy-FL-SKF-83566 is suitable for 
the pharmacological characterization of non-labelled dopaminergic 
ligands. The obtained results are in good agreement with the data 
obtained from the radioligand [3H]SCH  23390 binding experiments 
with the same baculovirus preparations. In conclusion, by using 
fl uorescence based detection assay, we are now able to perform real-
time monitoring of ligand binding. Obtained results demonstrate that 
fl uorescence anisotropy based assay is applicable for the study of 
dopamine receptors and their ligands.
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Previous studies of our group indicate that genetic deletion and 
pharmacological antagonism of P2Y12 receptors alleviate mechanical 
allodynia in acute infl ammatory pain. In this project we investigated 
the role of P2Y12 receptors in chronic infl ammation. For this study we 
have introduced a CFA-model in wild type and P2Y12R gene defi cient 
(P2ry12–/–) mice. By the injection of Complete Freund’s Adjuvant 
(CFA) in the plantar surface of the right hind paw, we could induce 
local infl ammation persisting at least 14  days. During this 2  week 
period, mechanical sensitivity was evaluated at several time points 
using dynamic plantar von Frey aesthesiometer. Mechanical allodynia 
could be observed 3 days after CFA injection. In P2Y12 receptor gene 
defi cient mice the decline in the paw withdrawal threshold (PWT) 
was signifi cantly lower than in wild type mice. Both intrathecal and 
intraplantar administration of PSB-0739, a selective and potent P2Y12 
receptor antagonist had robust antihyperalgesic eff ect in wild type 
mice, whereas treatment did not aff ect the PWT in the P2ry12–/– group. 
Intraperitoneal injection of A-803467, a potent and selective NaV1.8 
sodium channel blocker evoked antihyperalgesic eff ect similar to the 
PSB-0739. When these two compounds added together, no additive 
eff ect was observed, i.e. A-803467 occluded the eff ect of PSB-0739. To 
investigate whether P2Y12 receptors on thrombocytes contribute to 
this eff ect, we used anti-mouse CD41 antibodies to induce depletion 
of platelets. Mice were submitted to intraperitoneal injection of 
this antibody at the end of the fi rst week and measurement of the 
mechanical allodynia was performed on the second week. Our fi ndings 
indicate that P2Y12 receptor inhibition is a potential therapeutic 
approach in chronic infl ammatory pain, although its exact mechanism 
of action needs further investigation.
Keywords Infl ammation, pain, purin
P3
Acute stimulation of glycolytic fl ux in cultured primary astrocytes 
by the tyrosine kinase inhibitor tyrphostin 23
Eva-Maria Blumrich1,2, Reshma Kadam1, Ralf Dringen1,2
1Centre for Biomolecular Interactions Bremen, Faculty 2 (Biology/Chemistry), 
University of Bremen, Germany; 2Centre for Environmental Research and 
Sustainable Technology, University of Bremen, Germany
SpringerPlus 2015, 4(Suppl 1):P3
Tyrphostin 23 (T23) is a well-known inhibitor of protein tyrosine 
kinases. To investigate potential eff ects of T23 on the viability and the 
glucose metabolism of brain cells, we exposed cultured primary rat 
astrocytes to T23. While the viability and the morphology of the cells 
were not acutely aff ected during an incubation of the cultures for up 
to 4 hours with T23 in concentrations of up to 200 μM, the presence 
of T23 rapidly stimulated glycolytic fl ux as demonstrated by a time- 
and concentration-dependent increase in glucose consumption and 
lactate release. Maximal eff ects were observed for incubations with 
100  μM T23 which caused a doubling of glucose consumption and 
lactate production. The stimulation of glycolytic fl ux by T23 was fully 
reversible upon removal of the compound. In contrast to T23, the 
structurally related tyrosin kinase inhibitor tyrphostin 25 did not aff ect 
glycolytic fl ux, nor was the stimulation by T23 substantially aff ected 
by the trichloracetate-induced activation of pyruvate dehydrogenase. 
Further experiments are now required to elucidate the mechanism of 
T23-induced stimulation of astrocytic glycolysis.
Keywords Tyrphostin 23, astrocytes, glycolysis
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The ascending midbrain 5-HT neurons known to contain 5-HT1A auto-
receptors may be dysregulated in depression due to a reduced trophic 
support. New fi ndings show existence of FGFR1-5-HT1A heteroreceptor 
complexes in the rat hippocampus with a partial characterization 
of their interface and in midbrain raphe 5-HT nerve cells. With in situ 
Proximity Ligation Assay (PLA) and supported by co-location of the 
FGFR1 and 5-HT1A immunoreactivities in midbrain raphe 5-HT cells, 
evidence for the existence of FGFR1-5-HT1A heteroreceptor complexes 
were obtained in the dorsal and median raphe nuclei of the Sprague–
Dawley rat. Their existence in the rat medullary raphe RN33B cell cultures 
was also established. After combined FGF-2 and 8-OH-DPAT treatment, 
a marked and signifi cant increase in PLA positive clusters was found 
in the RN33B cells. Synergistic receptor-receptor interactions in these 
receptor complexes indicated their enhancing role in hippocampal 
plasticity. The existence of FGFR1-5-HT1A heteroreceptor complexes 
also in midbrain raphe 5-HT nerve cells open up the possibility that 
antidepressant drugs by increasing extracellular 5-HT levels, can 
cause an activation of the FGF-2/FGFR1 mechanism in these nerve 
cells as well. Therefore, the agonist modulation of the FGFR1-5-HT1A 
heteroreceptor complexes and their specifi c role is now determined in 
rat medullary raphe RN33B cells and in the caudal midline raphe area 
of the midbrain rich in 5-HT nerve cells. The combined icv treatment 
with FGF-2 and the 5-HT1A agonist 8-OHDPAT synergistically increased 
FGFR1 and ERK1/2 phosphorylation in the raphe midline area of the 
midbrain and in the RN33B cells. Cotreatment with FGF2 and the 
5-HT1A agonist induced RN33B cell diff erentiation as seen from 
development of the increased number and length of extensions per 
cell and their increased 5-HT immunoreactivity. These signaling and 
diff erentiation events were dependent on the receptor interface since 
they were blocked by incubation with TMV but not by TMII of the 
5-HT1A receptor. Taken together, the 5-HT1A autoreceptors by being 
part of a FGFR1-5-HT1A heteroreceptor complex in the midbrain raphe 
5-HT nerve cells appears to have also a trophic role in the central 5-HT 
neuron systems besides playing a key role in reducing the fi ring of 
these neurons.
Keywords Fibroblast growth factor receptor, serotonin 5-HT1A 
receptor, heteroreceptor complexes
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To test for potential consequences of an exposure of brain cells 
to copper oxide nanoparticles (CuO-NPs), we have synthesized 
dimercaptosuccinate-coated CuO-NPs. These particles had a diameter 
of around 5  nm as determined by transmission electron microscopy 
but were dispersed as aggregate as demonstrated by their average 
hydrodynamic diameter in aqueous dispersion of 136 ± 4 nm. Exposure 
of cultured primary astrocytes to CuO-NPs increased the cellular copper 
levels and compromised the cell viability in a time- and concentration-
dependent manner. CuO-NPs in concentrations above 100 μM (6.3 μg 
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copper/mL) severely aff ected the viability of the cells, as demonstrated 
by a lowered tetrazolium dye reduction capacity, a lowered cellular 
lactate dehydrogenase activity, a increased membrane permeability 
and the generation of reactive oxygen species. In contrast, exposure of 
astrocytes for 24 h with 100 μM CuO-NPs did hardly aff ect the viability 
of astrocytes but stimulated the glycolytic fl ux, increased the cellular 
glutathione content, stimulated the release of glutathione and elevated 
the level of the metal storing proteins metallothioneins. Presence of 
the intracellular copper chelator tetrathiomolybdate throughout the 
incubation with CuO-NPs protected the cells against the toxicity of 
CuO-NPs and prevented the stimulation of the glycolytic fl ux as well as 
the increased levels of metallothioneins. These data demonstrate that 
CuO-NPs can severely damage cultured astrocyes and that copper ions 
derived from sub-toxic concentrations of CuO-NPs strongly aff ected 
the metabolism of astrocytes.
Keywords Copper, nanoparticles, sstrocytes
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Motor neuronal system and muscle tissue are two districts diff erently 
aff ected at onset and during the progression of diseases like 
amyotrophic lateral sclerosis (ALS) or spinal and bulbar muscular 
atrophy (SBMA). The bases of these diseases are linked to mutated 
proteins: fALS is commonly caused by mutations in the SOD1 or the 
TDP43 genes and SBMA is caused by a of CAG repeat in the AR gene. 
A fraction of these proteins can not reach a mature conformation and 
misfold. The Protein Quality Control (PQC) system is responsible for 
the correct protein homeostasis: the chaperones maintain proteins in 
their correct conformations. If they fail, mutated proteins are directed 
to the proteasome or the macroautophagy. When misfolded proteins 
are not correctly removed, they aggregate in nucleus and cytoplasm. 
To understand cellular behavior in presence of misfolded toxic proteins 
we investigate the diff erent activation of the PQC system in the two 
mayor tissues involved. Initially we investigated the diff erences in 
PQC activation between NSC34 motor neuronal and C2C12 muscular 
cell models. Using RTq PCR, western blot and immunocytochemical 
analysis for p62 and LC3 expression, localization, and turnover we 
demonstrated that C2C12 cells have a more active autophagic system 
than NSC34 cells. Then, we compared the two models in presence 
of misfolded protein inhibiting degradative systems. With Filter 
Retardation Assay, we observed that these proteins tend to aggregate 
when PQC system is impaired. Then, we potentiated the PQC response 
to reduce the insoluble species. By overexpressing the small heat 
shock protein B8 in both systems we demonstrated that AR polyQ and 
SODG93A insoluble species were reduced. Also autophagy activation 
by trehalose caused a reduction in protein aggregation in both cell 
models. In conclusion misfolded protein aggregates can be reduced 
by modulating macroautophagy and this could represent a new 
therapeutical strategy for disease like SBMA and ALS.
Keywords Neurodegeneration, misfolded proteins, PQC system
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Nerve Growth Factor (NGF) plays a key role in development and function 
of specifi c neuronal populations of the CNS. Decreased NGF availability 
is also responsible for neuronal vulnerability in neurodegenerative 
disorders, such as Alzheimer’s disease (AD). We used PC12 cells and 
primary neurons to investigate the potential role of NGF in modulating 
neuronal autophagy, a cellular process whose deregulation has been 
linked to the loss of neuronal. The mammalian target of rapamycin has 
been recently proposed as a therapeutic target for AD due to the role 
of the autophagy pathway in improving cognitive function by reducing 
Aβ and Tau pathology. We here show that NGF treatment induces 
LC3 conversion (LC3-I to LC3-II), a marker of autophagy, through the 
activation of AMP-activated protein kinase (AMPK). We show that NGF 
increases the autophagic fl ux (the dynamic process of autophagosome 
synthesis, delivery to the lysosome and degradation) as indicated by 
western blot and fl uorescence microscopy analyses in the presence 
of autophagy inhibitors. These data were confi rmed by RT-PCR array 
analysis and RNA interference-mediated knockdown of autophagy-
related genes: Atg9b, Atg12 and AMBRA1, a positive regulator of 
the BECLIN 1-dependent program of autophagy. In addition, fl ow 
cytometry analysis by DCF-DA showed that treatment with autophagy 
inhibitors determined a strong increase of reactive oxygen species 
(ROS) followed by decreased cell survival. These changes were fully 
reversed by NGF treatment, suggesting its potential role in clearing 
dysfunctional mitochondria. This hypothesis was further confi rmed 
by fl uorescence microscopy studies using LC3 and Cox-IV antibodies, 
showing co-localization of autophagosomes and mitochondria. Overall 
these data identify a novel aspect of the neuroprotective function 
of NGF in promoting the clearance of dysfunctional mitochondria 
(or mitophagy), thus further supporting its therapeutic potential in 
neurodegenerative pathologies.
Keywords NGF, Alzheimer disease, autophagy
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Acute liver failure (ALF) instantly evokes symptoms of hepatic 
encephalopathy (HE), mainly attributed to hyperammonemia. 
Ammonia neurotoxicity is related to disturbances in the nitric 
oxide (NO)/cGMP pathway. The methylated derivative of L-arginine 
(MDALs) – asymmetric dimethylarginine (ADMA) but not symmetrically 
methylated arginine (SDMA) is an endogenous inhibitor of nitric 
oxide synthase. Elevated blood and brain ADMA was reported in 
HE patients and experimental animals. The question arose whether 
ALF evokes changes in the incorporation of the methyl donor 
S-adenosylmethionine (SAM) to MDALs, and how they aff ect cGMP 
accumulation. To this end, we investigated the eff ect of intracortical 
perfusion of SAM on the brain extracellular levels of ADMA, SDMA 
and cGMP in rats with ALF in the thioacetamide (TAA) model. Sprague 
Dawley rats (250–270 g) received three i.p. injections of TAA (300 mg/
kg) at 24  h intervals. Bilateral microdialysis of the prefrontal cortex 
was carried out 24  h after the last TAA administration. SAM at 2  mM 
concentration in artifi cial cerebrospinal fl uid was infused for 40 min and 
then the medium was changed back. The extracellular levels of ADMA 
and SDMA were analyzed using positive mode electrospray LC–DMS–
MS/MS and cGMP was determined with cGMP enzyme immunoassay. 
ALF resulted in the increased extracellular levels of ADMA (by ~800%) 
and SDMA (by ~250%). Moreover, in ALF rats infusion of SAM decreased 
the ADMA and SDMA (~30%) as compared to the basal value. It seems 
reasonable that an excessive amount of substrate inhibited the 
enzymes synthesizing MDALs. On the other hand, the cGMP level did 
not diff er between control and TAA rats. SAM increased by ~90% cGMP 
only in the control group, what indicates aff ected NO/cGMP pathway in 
TAA model. The study demonstrates, that ALF modulates methylation 
of arginine to MDALs in a manner aff ecting cGMP accumulation.
Acknowledgements This study was supported by Grant N 2013/09/B/
NZ4/00536 from the National Science Centre.
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Cerebral ischemic injuries and neurodegenerative disorders lead 
to death or impairment of neurons in the central nervous system. 
Application of stem cell based therapies, namely stimulation of 
endogenous neurogenesis or cell transplantation, are promising 
strategies and currently under investigation. Carbon monoxide (CO) 
is an endogenous product of heme degradation by heme oxygenase. 
Although there is no published data reporting CO as a factor involved 
in stem cell diff erentiation, several evidences support this hypothesis. 
This gasotransmitter induces mitochondrial biogenesis, which is also 
broadly described to be involved in metabolic shifts during neuronal 
diff erentiation process. Likewise, CO-induced pathways can occur via 
generation of small amounts of ROS, which are also important signaling 
molecules in neuronal diff erentiation. The CO eff ect on modulation 
of neuronal diff erentiation is assessed in three diff erent models with 
increasing complexity: human neuroblastome SH-S5Y5 cell line, 
human teratocarcinome NT2 cell line and hippocampal organotypic 
slice cultures (HOSC). CO does increase the fi nal yield of post-mitotic 
neurons. During neuronal diff erentiation, CO promotes an increase 
on precursor cell proliferation and in parallel CO inhibits cell death. 
Furthermore, cell mitochondrial population is increased by CORM-A1 
supplementation. Further work is needed for assessing the mechanisms 
underlying CO eff ects in neuronal diff erentiation, namely by targeting 
modulation of cellular metabolic pathways, redox alterations and 
autophagy related pathways. In conclusion, CO appears as a promising 
therapeutic molecule to stimulate endogenous neurogenesis or to 
improve in vitro neuronal production for cell therapy strategies.
Keywords Carbon monoxide, neuronal diff erentiation, 
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Receptor for advanced glycation end products (RAGE) triggers an 
intracellular signalling pathways of various proinfl ammatory ligands. 
Solubile form of RAGE (sRAGE) in human plasma can hinder the function 
of RAGE and can have the role in the pathogenesis of infl ammatory 
diseases. In patients with multiple sclerosis (MS), altered level of sRAGE 
in plasma and cerebrospinal fl uid has been found. In our study, we tried 
to identify possible association of sRAGE serum level with MS. Serum 
levels of sRAGE were detected by ELISA in 44 MS patients (22 patients 
with rapid progression of MS and 22 patients with slow progression of 
MS according to the MSSS score) and 32 healthy control subjects. We 
found signifi cantly increased level of sRAGE in serum of MS patients 
when compared to controls. No signifi cant diff erences in serum level of 
sRAGE where found between rapidly progressing and slow progressing 
subgroup of MS patients.Our results suggest for the role of sRAGE in 
MS ethiopathogenesis, but we did not fi nd any association of sRAGE in 
serum with the rate of MS disability progression.
Acknowledgements This work was supported by the grant MZ SR 
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Oxygen starvation is observed in a variety of pathological states 
and serves as one of the urgent problems in medicine. A decrease in 
oxygen supply to tissues is accompanied by the inhibition of metabolic 
processes (primarily of energy metabolism), which impairs functional 
activity of the brain. The main source of energy for brain is adenosine 
triphosphate (ATP). It was shown that the components of adenylate 
pool can be used as early predictors of hypoxia.
Aim of the study The aim of our study was analysis of adenosine 
triphosphate (ATP) and adenosine monophosphate (AMP) experimental 
concentrations and integral coeffi  cient K= in intact animals brain tissue 
and in disturbances of the oxygen regime by methods of mathematical 
analysis, as well as detection of some regularity in the character 
of their changes under the impact of hypoxia for the assessment 
and prediction of direction of production and utilization energy in 
metabolic pathways.
Methodology In this study empirical dependencies and criteria of 
statistical signifi cance of mathematical modeling of quantitative 
relation between specifi ed brain nucleotide stock indicators for the 
assessment and prognostication of brain energy state in extreme 
conditions were used.
Results and area of their application The use of empirical depen-
dencies methods allowed to create multiregression models, subtly 
enough to unite experimental indicators ATP and AMP in hypobaric 
hypoxia and ischemia with diff erent-term exposure. Obtained models 
can be used for prognostication of ATP and AMP concentrations in 
disturbances of the oxygen regime in a short or over a long period 
of time, as well as to receive information of indicator K= changing 
depending on brain hypoxia.
Conclusions functional dependencies are presented in this study to 
analyze shape, closeness and stability of relations between adenine 
nucleotides characterizing coupling of production and utilization 
energy processes, and also to predict the direction of these processes 
under hypoxic condition.
Keywords Adenylate pool, hypoxia, multiregression model
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Brain ischemia is accompanied by lowering of pHo and pHi. We 
investigated an infl uence of of acidosis on free radical formation 
in synaptosomes. Three models were used: 1)  Strong extracellular 
acidifi cation down to pHo  6.0; 2)  Moderate extracellular acidifi cation 
down to pHo 7.0; 3)  Intracellular acidifi cation induced by addition of 
1 mM amiloride corresponding to pHi decrease down to 6.65. We have 
shown that both types of extracellular acidifi cation, but not intracellular 
acidifi cation, increase DCFDA fl uorescence by calcium-independent 
way that refl ects free radical formation. These three treatments induce 
the rise of the dihydroethidium fl uorescence that reports synthesis 
of superoxide anion. However, the impact of low pHi on superoxide 
anion synthesis was less than induced by moderate extracellular 
acidifi cation. Mitochondrial uncoupler CCCP did not inhibit an increase 
of fl uorescence of both dyes at pHo 6.0. In contrast, superoxide anion 
synthesis at pHo  7.0 was almost completely eliminated by CCCP. 
Furthermore, using fl uorescent dyes JC-1 and rhodamine-123, we 
confi rmed that decrease of pHo leads to mitochondria depolarization. 
Low pHi was not eff ective. Iron chelator deferoxamine and antioxidant 
ionol are inhibits pH-induced increase of DCFDA fl uorescence, but 
does not infl uenced mitochondria depolarization. We are failed to 
found sodium infl ux monitored by fl uorescent dye Sodium Green 
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in case of low pHo. Involving of plasma membrane receptor which is 
distinct from acid-sensitive ion channels (ASIC) and electron transport 
chain of mitochondria for moderate acidifi cation can be suggested. 
Action of strong acidifi cation seems to be mediated by release of iron 
from proteins. We have shown that low pHo led to oxidative stress 
in neuronal presynaptic endings that might underlie the long term 
irreversible changing in synaptic transmission.
Acknowledgements This work was supported by Belorussian 
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Alzheimer’s disease (AD) is a neurodegenerative disease characterized 
by progressive loss of brain tissue and accumulation of amyloid-β(Aβ) 
and tau. Aggregation of Aβ peptides into amyloid plaques is considered 
to be a causative factor in AD, however the precise mechanism behind 
the AD onset has remained elusive. Oxidative stress (OS) is also 
characteristic to AD, but it is not known whether OS is a risk factor or 
a consequence of AD. It is assumed that Aβ aggregates generate free 
radicals in the presence of copper ions by participation of the Met35 
residue, which can increase the OS levels. The aim of our study was to 
establish the role of Met35 residue in the oxidation of Aβ and peptide 
aggregation processes. Oxidation of Aβ was studied in the presence of 
two redox-active compounds: H2O2 and copper ions. In the absence 
of copper ions the Met35 residue was readily oxidized by H2O2 in a 
two electron process. The fi brillization of Aβ with Met35 oxidized to 
sulfoxide was threefold slower compared to that of the native peptide. 
TEM analysis showed that the fi brils of native and oxidized peptides are 
similar. The relatively small inhibitory eff ect of Met35 oxidation on the 
fi brillization suggests that the possible variation in the Met oxidation 
state should not aff ect the in vivo plaque formation. In the presence of 
copper ions (one-electron process) the oxidation was more complex: 
addition of the fi rst oxygen was still the fastest process, however, it was 
accompanied by multiple unspecifi c modifi cations of several amino 
acid residues. Addition of copper ions to the already oxidized Aβ Met35 
by H2O2, resulted in a similar pattern of nonspecifi c modifi cations, 
suggesting that the one-electron oxidation processes in Aβ do not 
depend on the oxidation state of Met35. Thus, it can be concluded that 
Met35 residue is not a part of the radical generating mechanism of Aβ-
Cu(II) complex.
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The present study has examined several characteristics of the release 
of [3H]5-HT from the median raphe nucleus (MRN) and hippocampus 
in terms of its dependence of nerve impulse. We used electrical 
stimulation and the sodium channel opener veratridine, which 
excite all of the neuronal processes in the stimulation fi eld, and 
optogenetics to selectively stimulate those terminals which express 
channelrhodopsin-2 (ChR2) and compared 5-HT release evoked by 
electrical and chemical depolarization and by light. We injected an 
adeno-associated virus containing DNA construct encoding ChR2 into 
the MRN of mice and investigated [3H]5-HT release from MRN and 
hippocampal slices. Serotonergic nerve terminals was locally stimulated 
with 473  nm light (blue laser diode) and electrically by bipolar 
electrode and by veratridine and transmitter release was monitored by 
collecting the effl  uent in a fraction collector. Electrical fi led stimulation 
and veratridine resulted in a signifi cantly increase in the effl  ux of 
5-HT, whereas optical stimulation of ChR2 expressing nerve terminals 
at various frequencies (10, 20, 50, 100  Hz) elicited only a negligible 
increase in 5-HT release either from the hippocampus or from the MRN 
itself. The electrically induced release of radioactive neurotransmitter 
was completely inhibited by perfusion with tetrodotoxin. We have also 
applied the 5-HT transporter inhibitor, fl uoxetine and the GABAA blocker 
bicuculline to relieve released 5-HT from re-uptake and any endogenous 
inhibition. Nevertheless, the eff ect of optical stimulation remained 
closed to the detection limit under these condition. In conclusion, 
whereas our method is suitable to detect [3H]5-HT effl  ux in response 
to ongoing neuronal sodium channel activity its sensitivity is too low to 
detect transmitter effl  ux evoked by focal optogenetic stimulation. The 
most likely reason for the failure of detection of 5-HT effl  ux is that ChR2 is 
expressed only by a small subpopulation of nerve terminals.
Keywords Channelrhodopsin-2, median raphe nucleus, serotonin
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Recombinant human IgM22 (rHIgM22) binds to myelin and to 
oligodendrocytes, and promotes remyelination in a mouse model of 
multiple sclerosis [1]. rHIgM22 preferentially reacts with sulfatide-
positive (O4-positive) oligodendrocytes [1]. Moreover, binding of 
rHIgM22 is abolished in CNS tissue slices from Cst(–/–) mice [2], 
suggesting that its binding to myelin requires the presence of a 
product of cerebroside sulfotransferase, possibly sulfatide, abundantly 
expressed in oligodendrocytes and in myelin. However the exact 
identity of the antigen recognized by this antibody remains to be 
elucidated. We have tested the binding of rHIgM22 to purifi ed lipids and 
to lipid extracts prepared from mouse brain, brain myelin, mixed glial 
cultures, and O4-positive oligodendrocytes using TLC immunostaining 
and ELISA using liposomes and lipid monolayers with diff erent 
composition. Our preliminary results show that rHIgM22 binds to 
sulfatide in vitro, while it does not bind to other myelin sphingolipids, 
including galactosylceramide and sphingomyelin, suggesting that 
sulfatide at the oligodendrocyte surface might be important for 
the binding of rHIgM22 to the surface of these cells and to myelin. 
However, IgM22 does not bind structures expressing sulfatide outside 
the nervous system, thus additional factors are likely relevant for the 
immunoreactivity of IgM22 in CNS. Indeed, we have observed in lipid 
extracts from diff erent sources another lipid molecule selectively 
recognized by rHIgM22, whose identity is still under investigation. 
Remarkably, this lipid is also present in the extracts from mixed glial 
cultures, which do not contain mature O4-positive oligodendrocytes, 
suggesting that other glial cells in addition to oligodendrocytes might 
be important in the response to rHIgM22.
Acknowledgements This work was supported by Acorda Therapeutics.
Keywords Multiple sclerosis, remyelination, sulfatide
References
1. Warrington AE, et al. PNAS. 2000;97:6820-5.
2. Wright BR, et al. Arch Neurol. 2009;66:1456-9.
P16
Investigation of P2X7R involvement in maternal poly(i:C) exposure 
evoked autistic features in mice
Gergely Horváth, Lilla Otrokocsi, Ágnes Kittel, Mária Baranyi, Beáta Sperlágh
Hungarian Academy of Sciences Institute of Experimental Medicine, Hungary
SpringerPlus 2015, 4(Suppl 1):P16
Autism Spectrum Disorder (ASD) is a neurodevelopmental condition 
with core symptoms of unusual social interaction and communication 
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and increased repetitive behaviours with limited interests of 
environment. Recent studies have revealed that purinergic signalling 
(hyperpurinergia) is one of a key features of autism. Our aim was to 
establish a reliable model of ASD in our lab utilizing a broad range of 
behavioural experiments in order to investigate the role of P2X7 in 
autism. We injected Poly(I:C) (PIC) in two doses to pregnant C57Bl/6 
mice: 3 mg/kg on E12.5 and 1.5 mg/kg on E17.5 respectively. Off springs 
were weaned 4  weeks of age and behavioural studies started from 
8  weeks of age. We performed social preference test, measured the 
body temperature and sensorymotor coordination (rotarod). We 
used self grooming and marble burying test in order to investigate 
manifestation of repetitive behaviour and measured the sensorymotor 
gating with Prepulse Inhibition (PPI). After behavioural experiments 
animals were sacrifi ced. Para-sagittal sections of the cerebellar vermis 
were cut and Purkinje cells were counted. Synaptosome fractions were 
made from half brains of animals and examined by electron microscopy. 
Striatum and Hippocampus monoamine content were measured by 
HPLC. We compared PIC treated off springs with naive animals (n = 10–
16 animals/group). PIC treated animals showed decreased sociability 
and sensorymotoric coordination but we did not fi nd change in body 
temperature of PIC animals. MIA animals showed increased repetitive 
behaviour in the marble burying and self grooming test. Quantitative 
Purkinje cell dropout was found in PIC mice and electron microscopy 
of half brain revealed ultrastructural abnormalities in them. Higher 
level of monoamins were detected in ASD mice compared to the 
control group. Based on these results this model seem to be suitable to 
measure the eff ect of diff erent compounds or genetic deletion on PIC 
induced ASD symptoms in rodents.
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Alzheimer’s disease (AD) is a neurodegenerative disorder. The patho-
histological features in AD are intracellular accumulation of neuro-
fi brillary tangles and extracellular senile plaques. Plaque deposition 
leads to recruitment and activation of microglial cells, which induces 
neuroinfl ammation and drives neurodegeneration.Recent evidence 
show that soluble pre-fi brillar Aβ species, rather than insoluble fi brils, 
are highly neurotoxic and correlate with disease severity.Hence, 
preventing formation of soluble Aβ and its interaction with neurons is 
a major goal in AD. Despite massive eff orts, how extracellular factors 
regulate assembly of Aβ peptide and neurotoxic activity of Aβ species 
is still largely undefi ned. Recent studies indicate that Extracellular 
Vesicles(EVs),including exosomes and PM-derived microvesicles(MVs), 
may infl uence Aβ neurotoxicity. Our fi ndings reveal that production of 
microglial MVs(m-MVs) is strikingly high in patients with mild cognitive 
impairment and AD as compared to healthy controls and positively 
correlates with markers of neurodegeneration and hippocampal 
atrophy. Furthermore we found that MVs isolated from the CSF of 
AD patients are toxic to cultured hippocampal neurons. Through in 
vitro studies we demonstrate that the m-MVs promote generation of 
neurotoxic soluble species from almost inert Aβ aggregates, which 
is mediated by lipid components of MVs. Our fi ndings suggest that 
m-MVs favor formation of neurotoxic Aβspecies throughout the brain, 
possibly representing the mechanism behind transynaptic spread of 
Aβ in AD. On the other hand, studies conducted by Yuyama et al., 2012, 
2014, and An et al., 2013, suggest that exosomes produced by neurons 
may exert opposite action by neutralizing neurotoxicity of soluble Aβ. 
To verify if the overall eff ect of exosomes and MVs on Aβneurotoxicity 
may vary depending on parental cell type we are currently studying the 
infl uence of EVs (exosomes &MVs) derived from distinct brain cells on 
Aβ toxicity and assembly.
Keywords Extracellular vesicles (EVs), Alzheimer’s disease (AD), 
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In recent years the study of age-related derangements of the 
gonadotropin releasing hormone (GnRH) synthesis and secretion 
resulting from both the GnRH gene expression changes and interaction 
of glia with GnRH-ergic neurons of the hypothalamus is a focus of 
attention. It was demonstrated earlier that this could result from the 
decreased activity of monoaminergic and peptidergic systems that 
control the GnRH preovulatory secretion surge initiation, specifi cally 
from the loss of the signal coming from the suprachiasmatic nuclei (SCN) 
of the hypothalamus. This signal is critical for the emerging of the GnRH 
regular cyclic secretion, which is mediated prominently by vasoactive 
intestinal peptide (VIP). We have studied age-related changes in 
the biogenic amines and VIP content in the hypothalamic structures 
responsible for the GnRH synthesis and secretion. It has been shown by 
us that the GnRH level in the median eminence with the arcuate nuclei 
(ME-Arc) of the hypothalamus of 22-month-old rats is half as high 
compared to that of 7–8-month-old animals. Beside that, the VIP level in 
the SCN tended to decrease, with the norepinephrine, dopamine, and 
5-hydroxyindoleacetic acid levels decreased signifi cantly in the median 
preoptic area of the hypothalamus responsible for the GnRH synthesis 
and in the ME-Arc exercising its secretion into the portal vein of the 
pituitary. It has been shown that the initial phase of the reproductive 
failure with 13–14-month-old animals having irregular estrous cycles is 
characterized by gradual disappearance of the normal biogenic amine 
diurnal dynamics in the studied hypothalamic structures, which could 
be due to the loss of regulatory signals coming from the SCN.
Keywords GnRH, biogenic amines, hypothalamus
P19
Toxicity of amyloid beta 1-40 and 1-42 on SH-SY5Y cell line
Jekaterina Krishtal, Olga Bragina, Kristel Metsla, Peep Palumaa, Vello Tõugu
Tallinn University of Technology, Estonia
SpringerPlus 2015, 4(Suppl 1):P19
Objectives Amyloid beta plaques are primary hallmark of Alzheimer’s 
disease, which is characterized by specifi c neurodegeneration. 
Amyloid beta peptide – the main plaque component- was shown 
to be neurotoxic in animal models, primary neuronal cultures and 
immortalized cell lines. However, the results are often controversial and 
there is no good human cell line model for evaluation of the toxicity of 
amyloid peptides. Here we studied the eff ect of amyloid beta 1-40 and 
1-42 on undiff erentiated and diff erentiated human neuroblastoma cell 
line SH-SY5Y.
Results Undiff erentiated cell culture was too diverse and unstable 
to reveal a toxic eff ect of amyloid beta peptides quantitatively. 
Diff erentiated cells established more neuron-like phenotype and were 
more identical and stable in culture suggesting potential susceptibility 
to amyloid beta as a neurotoxic agent. Amyloid peptides are prone 
to form diff erent aggregates with diverse toxic properties, in current 
study, monomeric amyloid beta 1-40 and 1-42 were applied to the cells. 
Viability test WST-1 and propidium iodide (PI) uptake tests showed that 
undiff erentiated cells are not susceptible to amyloid beta, however, 
diff erentiated cells showed reduced viability and increased PI uptake in 
case of amyloid beta 1-42, but not in case of amyloid beta 1-40.
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Conclusions Current study revealed that amyloid beta has no 
remarkably toxic eff ect on undiff erentiated SH-SY5Y cell line whereas 
viability of the neuron-like diff erentiated cell culture is signifi cantly 
decreased by the amyloid beta 1-42 peptide that is known to form 
spontaneously toxic aggregates.
Keywords Amyloid beta, toxicity, SH-SY5Y
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The present study was undertaken to reveal the eff ects of chronic arsenic 
exposure (25  ppm intragastrically for 12  weeks) on mitochondrial 
functions and oxidative stress in male Wister rats. Chronic arsenic 
exposure resulted in decrease in the activities of the mitochondrial 
complexes. There was increased generation of ROS followed by 
decrease in MnSOD activity. The generation of oxidative stress was 
associated with increased protein oxidation and lipid peroxidation 
in rat brain as evident by FTIR spectra. The RT-PCR analysis of NRF 1, 
NRF 2 and PGC 1α revealed decrease in gene expression suggesting 
decreased biogenesis following chronic exposure in rat brain. Thus, 
the fi ndings of the present study reveal that arsenic induced decrease 
in mitochondrial biogenesis may be responsible for the decreased 
metabolic response that may be further involved in the generation of 
oxidative stress and neurodegeneration in rat brain.
Keywords Arsenic, oxidative stress, mitochondria
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Ichemic-reperfusion injury induced by four vessel occlusion aff ects 
vulnerable hippocampal CA1 (cornus ammonis 1) pyramidal neurons.
Ischemic tolerance evoked by preconditioning (IPC) represents a 
phenomenon of CNS adaptation to any subsequent ischemia. We refer 
here for the changes in the external signal receptor protein kinase 
pathways of the hippocampal area following by IPC. Ischemia was 
induced by a 4-vessels occlusion (4VO) and the rats were preconditioned 
by a non-injurious ischemia. Apoptotic markers were used to follow 
the degeneration process. Western blot and immunohistochemistry 
identifi ed phosphorylated extracellular signal-regulated protein kinase 
and p38 proteins in injured hippocampal areas. P-ERK quantifi cation 
increased after IPC and reached the highest level at 24 h after ischemia. 
Interestingly, neuroprotection induced by IPC lead to the opposite 
eff ect on MAPK/p38, where the level was lowest at 24 h after ischemia. 
The study clearly shows that phosphorylated form takes part in complex 
cascades triggered by IPC in the selectively vulnerable hippocampal 
region. In addition, study reveals an interplay between p-ERK and 
p-p38 which participates in the tolerence mechanisminduced by 
preconditioning.
Acknowledgements Study was supported by VEGA 213/12, MZ SR 
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Wolfram syndrome 1 (WFS1) is a genetic disorder which has been 
asso ciated both with impaired early brain development and neuro-
degeneration. Recent studies have suggested regulation of Ca2+ 
homeostasis by wolframin (Wfs1) and have demonstrated the 
involvement of endoplasmatic reticulum (ER) stress in Wfs1 defi ciency. 
Despite the ER dysfunction WFS1 shows several characteristics 
of pathologies related to mitochondrial dynamics. Therefore our 
aim was to examine the hypothesis that Wfs1 defi ciency could 
disturb mitochondrial dynamics contributing to impaired neuronal 
functioning. First we show that Wfs1 defi ciency induces mild ER stress 
leading to Inositol 1,4,5-Trisphosphate Receptor (IP3R) dysfunction 
and disturbed cytosolic Ca2+ homeostasis, which, in turn alters 
mitochondrial traffi  cking, inhibits mitochondrial fusion and augments 
mitophagy. The overexpression of the active IP3R fragment restores 
IP3R-mediated Ca2+ release and corrects all perturbations in 
mitochondrial dynamics suggesting that these events are causally 
linked. We further demonstrate that suppressing the expression of two 
Parkinson disease-related proteins, Pink1 and Parkin, leads to reduced 
Wfs1 defi ciency-induced mitophagy and also to the correction of 
the fusion-fi ssion dynamics and mitochondrial motility. These data 
suggest that Wfs1 defi ciency may over-activate Pink1 and Parkin 
pathways. Our most important discovery is that Wfs1 defi ciency delays 
neuronal development and axonal growth in primary rat cortical 
neurons. According to our data, the link between Wfs1 defi ciency 
and delayed neuronal development appears to be mediated by 
impaired mitochondrial dynamics because suppression of the Pink1-
Parkin pathway corrected also the developmental delay. Our data 
shed light on the mechanisms of neuronal abnormalities in WFS1 and 
point out potential therapeutic targets. This work may have broader 
implications for understanding the role of mitochondrial dynamics in 
neuropsychiatric diseases.
Keywords Mitochondrial dynamics, ER stress, neuronal development
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Melanocortin receptors (MCRs) are seven transmembrane G protein-
coupled receptors that are known for their broad physiological 
relevance. The subtype 4 melanocortin receptor (MC4R) has emerged 
as a central element in the regulation of energy homeostasis, eating 
behavior and regulation of sexual functions. MCRs are governed by 
a complex dynamic homotropic regulation [1]. There is an increasing 
trend towards using fl uorescence anisotropy (FA) for studying the 
aforementioned complex receptor-ligand interactions. FA allows the 
characterization of ligand binding dynamics [2]. The quality of the 
FA assay can be greatly increased with budded baculovirus particles 
that display the receptors of interest on their surfaces [3]. The use of 
a fl uorescent ligand Cy3B-NDP-α-MSH has made it possible to study 
MC4Rs with higher precision and sampling rate [3]. However, this 
ligand has relatively slow kinetics. Modifi cation of the structure of 
a MC4R antagonist revealed two new reporter ligands (UTBC101 
and UTBC102) for fl uorescence labeling. These new reporter ligands 
selectively bind to MC4Rs and exhibit improved kinetic properties. The 
association and dissociation rate constants of UTBC101 and UTBC102 
are kon = ((2.0 ± 0.6) × 107 M–1 min–1), koff  = ((4.6 ± 0.3) × 10–3 min–1) 
and kon = ((1.9 ± 0.5) × 107 M–1 min–1)), koff  = ((1.0 ± 0.2) × 10–1 min–1), 
accordingly. UTBC101 and UTBC102 enable the characterization of 
both labelled and non-labelled ligand binding dynamics in regard to 
the MC4R. UTBC102 could be especially valuable for ligand screening, 
because of its very high dissociation rate, which makes it possible to 
achieve equilibrium conditions.
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Neural cell adhesion molecule (NCAM) plays important roles in the 
regulation of the brain plasticity during its development and in 
adulthood. NCAM functions may be regulated by the addition of 
long linear homopolymers of alpha 2-8-linked sialic acid (PSA). PSA is 
attached to NCAM via either of two specifi c sialyltransferases: ST8SiaII 
and ST8SiaIV. PSA-NCAM is expressed abundantly in the retina and optic 
nerve during development and adulthood. In the retina PSA-NCAM is 
expressed in the glial cells in close proximity to retinal ganglion cell 
(RGC). The functions of the PSA-NCAM in the retina remain unknown. 
The aim of this study was to investigate the roles of PSA-NCAM in the 
survival of RGCs after administration of the exitotoxin kainic acid (KA). 
Intraocular administration of KA induced reduction in the density of 
RGCs approximately by 60%. Administration of endoneuraminidase 
(Endo-N) an enzyme, which removes PSA residues from the surface of 
NCAM, enhanced the toxic eff ect of KA on RGC. In knockout mice with 
constitutive defi ciency of either ST8SiaII or ST8SiaIV genes, the levels of 
PSA-NCAM did not diff er from those in wild type mice. The toxicity of 
KA on RGC in these animals also did not diff er from control. It should 
be noted, however, that in knockout ST8SiaII–/– adult mice a reduced 
number of RGCs was found despite the presence of high levels of PSA-
NCAM. These data suggest that during development ST8SiaII ensures 
high levels of PSA-NCAM, which necessary for the developmental 
survival of RGCs. The PSA-NCAM in the adult retina ensures the 
resistance of RGCs to injury.
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During early development neurons undergo complex morphological 
rearrangements. This active axo-dendritic growth must be supported 
by suffi  cient cellular energy, thus, cellular energy status could be a key 
factor in initiating this process. However, the precise mechanisms of 
how cells adapt their energetic status to physiological demand and 
upcoming energy needs and how they are coupled to adaptive energy 
generation, e.g., increased ATP production by mitochondria, remain 
unclear. Previous studies have shown that peroxisome-proliferator-
activated receptor gamma co-activator 1 (PGC-1α) is a master regulator 
of mitochondrial biogenesis and cellular energy metabolism. Our aim 
was to examine whether neuronal growth depends on mitochondrial 
biogenesis and whether activation of cell growth pathways could 
promote mitochondrial biogenesis to support the energetic need of 
neuronal development. Over-expression of PGC-1α in cortical neurons 
increased mitochondrial density in the periphery of axonal tree and was 
two-fold higher in axonal tips compared to control group. Moreover, 
induction of mitochondrial biogenesis by PGC-1α facilitated the axonal 
growth and neuronal development. Activation of PGC-1α upstream 
kinases such as Ca2+/calmodulin-dependent protein kinase kinase 2 
(CaMKK2), transforming growth factor-β-activated kinase (TAK1) and 
STE-related adaptor (STRAD) increased PGC-1α transcriptional activity 
and mitochondrial density in axons. Most importantly, they promoted 
neuronal development through mitochondrial biogenesis. This study 
shows that mitochondrial biogenesis itself is limiting factor for axonal 
growth and AMPK-PGC-1α upstream pathways sensing cellular energy 
status could signal not only the energy defi cit but also upcoming 
energy need to generate new mitochondria.
Keywords Mitochondrial biogenesis, PGC-1α, neuronal development
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GPR37 is a G protein-coupled receptor that is abundantly expressed 
in the brain and has been implicated in dopaminergic signaling [1]. 
The receptor has been identifi ed as a substrate of the ubiquitin ligase 
parkin and it has been linked to the autosomal recessive juvenile 
parkinsonism (AR-JP), an early onset familial Parkinson’s disease. The 
loss of parkin function and defi cits in the ubiquitin proteasome pathway 
were proposed to cause intracellular accumulation of unfolded GPR37 
leading to the AR-JP pathogenesis [2]. Here, we found that while 
GPR37 appears to mature normally in a heterologous expression 
system, the receptor is subject to proteolytic cleavage at its large 
N-terminal extracellular region. To study this proteolytic processing, 
we used stably and transiently transfected human embryonic kidney 
(HEK) 293 and SH-SY5Y neuroblastoma cells that express N- and 
C-terminally epitope-tagged human GPR37. N-terminal sequencing 
of the cleaved C-terminal receptor fragment revealed that GPR37 is 
cleaved between Glu187and Gln188 and the metabolic pulse-chase 
data suggests that receptor cleavage is a rapid and effi  cient process. 
Moreover, our results indicate that the receptor N-terminus is released 
from the cells by shedding, a phenomenon rarely described for GPCRs. 
Immunofl uorescence microscopy with subcellular markers indicates 
that GPR37 is still in the full-length form in the trans-Golgi network 
but is predominantly expressed in the cleaved form at the cell surface. 
Additionally, experiments with various proteinase inhibitors imply 
that the receptor is cleaved by a metalloproteinase. As proteolytic 
processing is involved in the regulation of many cell surface receptors, 
our fi ndings provide valuable information about GPR37 that help to 
understand its function and role in AR-JP at the molecular level.
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The comprehension of the mechanisms at the basis of astrocytic 
dysfunction in ALS is crucial to limit neuronal injury. Most of the toxic 
astrocytic eff ects highlight the role of intracellular calcium. S100B is a 
Ca2+-binding protein particularly present in astrocytes, behaving as 
a neuroinfl ammatory mediator as it is secreted by astrocytes under 
pathological conditions and can display paracrine toxicity by binding 
to RAGE. During ALS progression S100B increases in patient astrocytes 
and, in a rat model of the disease, S100B is augmented in “aberrant 
astrocytes”, characterized by their neurotoxic potential. The induction 
of S100B in astrocytes, its release and its interaction with RAGE in 
motoneurons could represent a hazardous mechanism that takes 
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place during ALS. Main objectives of this work were to investigate 1) if 
the expression of S100B protein and RAGE change during the course 
of the disease in rodent models of ALS, 2) if the expression of mutant 
SOD1 protein per se is suffi  cient to modify S100B levels in astrocytic 
cultures. We observed that S100B levels and localization are modulated 
in the spinal cord and in the brain cortex of rat and mouse models of 
ALS. We also demonstrated a diff erential expression of RAGE subunits 
in SOD1-G93A-derived CNS tissues. Moreover, we showed that the 
overexpression of mutant SOD1 in astrocytic cell line is suffi  cient 
to increase the intracellular levels and release of S100B, while it is 
not enough to induce a diff erential expression of RAGE. Thus, the 
expression of mutant SOD1 interferes with the physiological expression 
of S100B and RAGE and reveals that in astrocytes S100B modulation is 
an early event related to the mere expression of mutant SOD1, while 
the dysregulation of RAGE might be a phenomenon possibly requiring 
a more complex interplay between diff erent cell types and pathways. 
Overall, these data suggest that S100B might be a toxic mediator 
released by astrocytes in the ALS-linked neuroinfl ammatory process.
Keywords S100B, RAGE, ALS
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Toxic eff ects of ammonia in the brain are partly related to impaired NO 
production which depending on the dose/time of ammonia exposure, 
may be either increased or decrease. Asymmetric dimethylarginine 
(ADMA), is endogenous NOSs inhibitor and symmetric dimethylarginine 
(SDMA) is arginine (Arg) transport inhibitor (Teerlink et al., 2009). 
Previously we reported an increase of ADMA and SDMA concentration 
in brain of rats with acute liver failure (Milewski et al., 2014), but 
distribution of the ADMA/SDMA surplus between the particular 
intra and extracellular compartments has not been studied. Here, we 
measured the intracellular concentration of ADMA, SDMA and ADMA/
SDMA/NO precursor Arg, in cultured cortical astrocytes and rat brain 
endothelium cells (RBE-4) treated or not with ammonia. In RBE-4 
cells not treated with ammonia the ADMA concentration was twice 
higher and the Arg/ADMA ratio was much lower than in astrocytes, 
confi rming the well documented role of ADMA in endothelial NOS 
inhibition (Pope et al., 2009). Treatment for 48 h with 5 mM ammonia 
led to an almost 50% reduction of ADMA and SDMA concentration in 
both cell type. Since ammonia-dependent Arg transport in astrocytes 
is specifi cally mediated by the heteromeric Arg/Gln transporter y+LAT2 
(Zielińska et al., 2012), we speculated that this may also hold for both 
Arg derivatives. Indeed, silencing of the y+LAT2 gene diminished the 
reduction of intracellular ADMA concentration caused by ammonia 
treatment in astrocytes. Moreover, the y+LAT2-dependent component 
of ammonia-evoked Arg uptake was reduced in the presence of ADMA 
in the medium. The results suggest that increased ADMA (and possibly 
SDMA) effl  ux mediated by upregulated y+LAT2 may be one of the 
ways in which ammonia interferes with intra-astrocytic ADMA content 
and, subsequently, NO synthesis. Studies are underway to establish if 
the same sequence of changes holds for ammonia-treated cerebral 
endothelial cells.
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Synapse and dendrite defi cits induced by mutations in the X-linked 
intellectual disability gene Il1rapl1 Caterina Montani, Mariana 
Ramos-Brossier, Pierre Billuart, Carlo Sala Mutations and deletions 
of Interleukin-1 receptor accessory protein like 1 (IL1RAPL1) gene, 
localized on X chromosome, are associated to intellectual disability (ID) 
and autism spectrum disorder (ASD). IL1RAPL1 protein is localized at 
the postsynaptic compartment of excitatory synapses and plays a role 
in synapse formation and stabilization. Our project was to characterize 
IL1RAPL1 mutants identifi ed in patients with ID and ASD and to 
perform a behavioral and neuronal morphology analysis on IL1RAPL1 
KO mice. Specifi cally, we studied the function of three novel mutations 
of IL1RAPL1 gene in patients presenting ID. We found that two of the 
studied mutants lead to a partial loss of function of IL1RAPL1 and 
we pointed out the important function of the extracellular domain 
for the trans-synaptic PTPδ/IL1RAPL1 interaction in synaptogenesis. 
We also characterized the role of IL1RAPL1 wild type and mutants in 
regulating dendrite morphology using in vitro neuronal cultures and 
IL1RAPL1 KO mice. We identifi ed, associated to hippocampal cognitive 
impairment an increased number of dendrite branching points in CA1 
and CA2 hippocampal neurons of IL1RAPL1 KO mice. In transfected 
hippocampal neurons the overexpression of full length IL1RAPL1 and 
mutants lacking part of C-terminal domains leads to a simplifi cation of 
neuronal arborisation. This eff ect is abolished when we overexpressed 
mutants lacking part of N-terminal domains. Our results indicate 
the importance of IL1RAPL1 extracellular domains not only in 
synaptogenesis but also in dendrite development. We also concluded 
that for this activity PTPδ interaction is not required, suggesting that 
an unknown IL1RAPL1 binding partner is involved in the eff ect on 
dendrite morphology.
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L-carnitine is essential for translocation of fatty acids for their 
mitochondrial oxidation, a process shown in the brain to take place 
in astrocytes. However, it is not synthesized in the brain and has to 
be transported to brain cells. Organic cation/carnitine transporter 
novel family member 2  – OCTN2 (SLC22A5) presence was shown in 
endothelial cells forming the blood-brain barrier, as well as in neurons 
and astrocytes. We showed that OCTN2 activity in astrocytes and its 
presence in plasma membrane are higher upon activation of protein 
kinase C (PKC), but no phosphorylation of OCTN2 was detected. 
Therefore, we aimed to identify OCTN2-interacting partners and to 
defi ne their role in transporter regulation. Mass spectrometry analysis 
identifi ed several cytoskeletal, ribosomal, mitochondrial, and heat-
shock proteins as well as the proteins involved in signaling pathway 
and traffi  cking. We focused on protein phosphatase PP2A subunits 
identifi ed in OCTN2 proteome and we observed co-precipitation 
of OCTN2 with PP2A structural (A) and catalytic (C) subunits, as well 
as with two regulatory subunits  – striatin and SG2NA. Activation 
of PKC with phorbol ester (PMA) did not change the amount of co-
precipitating subunits A and C but signifi cantly lowered the amount of 
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co-precipitating SG2NA. Immunocytochemistry analysis of astrocytes 
showed OCTN2 co-localization with PP2A C subunit and with SG2NA 
in vesicular structures in the cytoplasm. PMA treatment did not change 
this co-localization, although an augmented amount of OCTN2 was 
detected in plasma membrane. We postulate that interaction of OCTN2 
with PP2A arrests the transporter in cytoplasm in dephosphorylated 
state, while PKC activation releases SG2NA subunit from the complex, 
resulting in transporter traffi  cking to the cell surface.
Acknowledgements This work has been fi nanced by grant 2012/07/B/
NZ3/00225 from National Science Centre in Poland.
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Adenosine receptors play critical roles in cellular processes and signaling 
and have been shown to form heteromers with diverse biochemical 
and/or pharmacological activities that are diff erent from those of the 
corresponding homomers1. However, despite extensive experimental 
results supporting the formation of adenosine heteromers in 
heterologous systems, the existence of such heteroreceptor complexes 
in the brain remains largely unknown, mainly because of the lack of 
appropriate methodology. Also no systematic study was carried out on 
heteromers form by adenosine receptor subtypes alone. In this study, 
we used several experimental approaches2 to investigate whether 
adenosine receptor A2A and A1 subtypes can form heteromers 
among themselves. In situ PLA clearly demonstrated that adenosine 
receptors (A2A-A2A, A2A-A1) exist as homo/heteroreceptor complexes 
in rat brain. In the hippocampus, A2A-A1 heteroreceptor complexes 
are mainly localized to the pyramidal cell layer of the Ammon´s horn 
and the hilo (PoDG). The complex was also observed throughout the 
piriformis layer. Several distinct diff erences were apparent between 
the distribution of the A2A-A1 heteroreceptor complexes and that of 
the A2A-A2A homoreceptor complex, which could have important 
functional consequences. Furthermore, bioluminescence resonance 
energy transfer analysis of adenosine A2A receptors established that 
they can physically interact in HEK293T27 cells, as both homomers 
and heteromers. In addition, static/non-dynamical human GPCR data 
derived from this and other interaction studies were integrated in a 
large scale graph, called the GPCR heterodimer network (http://www.
iiia.csic.es/~ismel/GPCR-Nets/index.html), which provides global insight 
into adenosine heteromer connectivity, topology and organization in 
the context of the adenosine receptor subfamily and the GPCR network 
as a whole.
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Quantitative real-time reverse transcription-polymerase (qRT-PCR) is 
a widely used technique to characterize changes in gene expression 
in complex cellular and tissue processes, such as the cytoprotection 
or infl ammation. The selection of an adequate internal reference gene 
for accurate and consistent analysis of gene expression is of major 
importance. Carbon monoxide (CO) aff ects several metabolic pathways 
and de novo protein synthesis is crucial in the cellular responses to 
the gasotransmitter. Herein a selection of commonly used reference 
genes was analyzed to identify the most suitable internal control 
genes to evaluate the eff ect of the CO on gene expression in cultured 
cortical astrocytes. The cells were exposed to CO by incubation with 
CORM-A1 (CO releasing molecule A1) and four diff erent algorithms 
(geNorm, NormFinder, Delta Ct and BestKeeper) were applied to better 
evaluate the stability of eight putative reference genes. Our results 
indicate that Gapdh (glyceraldehyde-3-phosphate dehydrogenase) 
and Ppia (peptidylpropyl isomerase A) is the most suitable gene pair 
for normalization of qRT-PCR results under the experimental conditions 
used. Pgk1 (phosphoglycerate kinase 1), Hprt1 (hypoxanthine guanine 
phosphoribosyl transferase I), Sdha (Succinate Dehydrogenase 
Complex, Subunit A), Tbp (TATA box binding protein), Actg1 (actin 
gamma 1) and Rn18s (18S rRNA) genes presented less stable expression 
profi les in cultured cortical astrocytes exposed to CORM-1 for up to 
60  min. Analysis of the eff ects of CO on the expression of Bdnf and 
bcl-2 gave diff erent results depending on the reference genes used. A 
signifi cant increase in the expression of both genes was found when 
the results were normalized with Gapdh and Ppia, in contrast with the 
results obtained when the other genes were used as reference. This 
study highlights the need for proper and accurate usage of reference 
genes in quantifi cation of qRT-PCR results in studies on the eff ect of CO 
in gene expression.
Keywords Carbon monoxide, astrocytes, reference genees
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Although depression is one of the prevailing central nervous system 
disorders, there is still not enough knowledge about the exact 
alterations underlying its pathophysiology and the treatment is 
often ineffi  cient. Our study aims at exploring a potential relationship 
between major depressive disorder and the purinergic P2X7 receptor 
(P2X7R), since in previous behavioural tests P2rx7 knock out mice 
displayed an antidepressant-like phenotype. Among many other 
known symptoms, the loss of hippocampal spine synapses is a 
revealing feature of the disorder. Therefore we wanted to measure 
the density of spine synapses in the molecular layer of the dentate 
gyrus in the learned helplessness paradigm and later see if genetic 
inhibition of P2X7R could have infl uence on this condition. Wild type 
C57Bl/6 and P2rx7 knock out male mice were exposed to inescapable 
footshocks (IES) in shuttle boxes during 2 training days and on the 3rd 
day learned helplessness was tested, where helpless animals usually 
failed to escape. Control animals were also placed in shuttle boxes but 
did not receive footshocks until testing. Escape failures and the latency 
to escape were measured to determine helpless behaviour. Electron 
microscopy analysis was performed to determine spine synapse density 
in the diff erent groups. In wild type mice both average escape latency 
and the number of failed escapes were signifi cantly higher in the IES 
treated group, however, we could not fi nd such divergency in P2rx7 
knock out mice. Electron microscopy analysis confi rmed alterations 
in spine synapse density in the molecular layer of the dentate gyrus 
subsequent to learned helplessness experiments, as results indicated a 
signifi cant decrease in spine synapse density in wild type mice, but not 
in knock out animals. These fi ndings may lead to presume a role of the 
P2X7 receptor in this disorder and further experiments will hopefully 
help get a better understanding and thus more eff ective treatment of 
major depression.
Keywords p2x7, depression, spine synapse
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Maintaining a neurotrophic support after peripheral nerve injury can be 
a key point in reducing the plastic changes which neurons, microglia, 
and astrocytes in the ventral horn undergo due to the loss of aff erent 
synaptic and neurotrophic stimuli originating from the periphery. 
Therefore, intrathecal administration of trophic factors or the inhibition 
of the mechanisms responsible for their degradation could help prevent 
these changes. The purpose of our study was to analyze the changes in 
the ventral horn produced by gliopathy determined by the suff ering of 
the motor neurons after peripheral nerve injury following spared nerve 
injury (SNI) of the sciatic nerve and how the administration of NGF or 
its synthetic analogue BB14, as well as the increase of endogenous 
NGF levels by i.t. infusion of GM6001, a MMPs inhibitor modulate these 
events. Immunohistochemical analysis of spinal cord sections revealed 
that SNI was associated with increased microglial (Iba1) and astrocytic 
(GFAP) responses, indicative of reactive gliosis. These changes were 
paralleled by decreased glial aminoacid transporters GLT1 and GlyT1, 
and increased levels of neuronal glutamate transporter EAAC1, this 
maladaptive behavior of neuronal and glial EAATs is paralleled by a net 
increase of the Glutamate/GABA ratio as measured by HPLC analysis. 
These molecular changes were found to be linked to an alteration of 
endogenous NGF metabolism, as demonstrated by decreased levels of 
mature NGF. The continuous i.t. NGF infusion or of its analogue BB14, or 
of the generic MMPs inhibitor GM6001 reduced reactive astrogliosis and 
normalized the expression of neuronal and glial glutamate and glycine 
transporters, restoring the reduction of the Glutamate/GABA ratio but 
it showed to be absolutely ineff ective in modifying the reactivity of 
microglia, demonstrating that the two glial populations have diff erent 
mechanisms of modulation associate to neuronal damage.
Keywords Gliopathy, motoneuron axotomy, NGF
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Mutations in Leucine-rich repeat kinase 2 gene (LRRK2) are associated 
with familial and sporadic Parkinson’s disease (PD). LRRK2 is a 
complex protein that consists of multiple domains executing several 
functions, including GTP hydrolysis, kinase activity and a C-terminal 
WD40 domain devoted to protein binding. Robust evidence suggests 
that LRRK2 acts at the synaptic site as a molecular hub connecting 
synaptic vesicles to cytoskeletal elements via a complex panel of 
protein-protein interactions. We have investigated the impact of 
pharmacological inhibition of LRRK2 kinase activity on synaptic 
function. Acute treatment with LRRK2 inhibitors reduced the frequency 
of spontaneous currents, the rate of synaptic vesicle traffi  cking and 
the release of neurotransmitter from isolated synaptosomes. The 
investigation of complementary models lacking LRRK2 expression 
allowed us to exclude potential off -side eff ects of kinase inhibitors 
on synaptic functions. Next we studied whether kinase inhibition 
aff ects LRRK2 heterologous interactions. We found that the binding 
among LRRK2, presynaptic proteins and synaptic vesicles is aff ected 
by kinase inhibition. Interestingly, a sequence variant (G2385R) within 
the WD40 domain has been implicated as a risk factor in PD, but its 
physiological and pathological function has not been systematically 
addressed yet. We analyzed molecular features of the WD40 domain 
and we addressed the functional implication of the G2385R variant. 
Our results suggest that LRRK2 WD40 domain serves as a hub for 
protein interactions setting LRRK2 as part of a protein network involved 
in synaptic vesicle traffi  cking. Furthermore we showed that the G2385R 
mutation infl uences WD40 domain features in terms of domain folding 
and binding properties and has an impact on synaptic vesicle dynamic. 
Our results suggest that diff erent PD mutation might infl uence synaptic 
vesicle release via modulation of LRRK2 macro-molecular complex.
Keywords LRRK2, synaptic vesicle, Parkinson’s disease
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Background GABAergic inhibitory action regulates learning/memory 
processes and contributes to neurotransmission (Gong et al., 
2009). Existing evidence suggests GABAergic system is involved 
in pathophysiology of Alzheimer’s disease (AD) via inhibitory 
interneuron defi cits (Verret et al., 2012) and decrease in functional 
GABAA receptors (Limon et al., 2012). In vitro, GABA and muscimol 
(GABAA receptor agonist) blocked neuronal death induced by Aβ in 
rat hippocampal and cortical neurons (Paula-Lima et al., 2005). Our 
concept: low doses of muscimol may prevent learning/memory defi cits 
in intracerebroventricular (icv) streptozocin (STZ)-induced AD non-
transgenic rat model.
Methods Wistar male rats (280  ±  20  g) were pre-treated with saline 
(control) or muscimol (0.01 and 0.05  mg/kg) for 3  days. On day  4, 
rats received icv STZ (100  μg/ml) or aCSF. From day 18, rats received 
muscimol or saline for 4  days; rat spatial learning and memory were 
assessed in water maze test (4 trials/day) by recording the time to reach 
the hidden platform (escape latency). A probe trial without platform 
was carried out 24 h after the training trials, and the number of platform 
zone crossings has been recorded.
Results STZ statistically increased the escape latency vs. control group 
(p < 0.0001). Muscimol at both doses signifi cantly decreased the escape 
latency in STZ rats vs. STZ, reversing STZ eff ect by about 90% on days 3 
and 4 (p < 0.0001). In probe trial, the number of platform crossings in 
muscimol+STZ rats’ was signifi cantly increased vs. STZ rats. Muscimol at 
both doses per se showed values comparable to control.
Conclusions Obtained data suggest that icv STZ signifi cantly decreased 
rat spatial learning and memory and learning ability. Muscimol at both 
low doses signifi cantly improved rats’ learning and memory abilities in 
both normal and AD-type rats. One may suggest that intensifi cation of 
GABAergic processes may be a useful pharmacotherapeutic strategy to 
halt early memory decline in AD.
Keywords Memory, muscimol, streptozocin
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Drug addiction is regarded as one of the most important neuro-
psychiatric diseases affl  icting our society today. A prototypic drug of 
abuse is cocaine which directly acts on the brain reward system. In this 
work we present evidence on the existence of dopamine D2R- Sigma1R 
heteroreceptor complexes which may play a role in the etiology of 
cocaine addiction. By means of BRET D2R-Sigma1R heteromers were 
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demonstrated in HEK293 cells after receptor cotransfection. The 
existence of D2R-Sigma1R heteroreceptor complexes was demon-
strated also in discrete regions of the ventral and dorsal striatum with 
in situ proximity ligation assay. Through saturation binding assay it was 
clearly demonstrated that in membrane preparations of HEK293 cells 
co-expressing D2R-Sigma1R, cocaine (1  nM) signifi cantly increased 
the D2R Bmax values (998  ±  40  fmol/mg protein) over D2R alone 
cells (664 ± 37 fmol/mg protein). This eff ect was counteracted by the 
Sigma1R selective antagonist PD144418 (Bmax value: 728 ± 39 fmol/mg 
protein). Furthermore, CREB reporter luc-gene assay indicated that the 
presence of D2R-Sigma1R signifi cantly reduced the potency of the D2R 
like agonist quinpirole to inhibit the forskolin induced increase of the 
CREB signal. In contrast, the presence of a low concentration of cocaine 
(100nM) was found to markedly increase the quinpirole potency to 
inhibit the forskolin induced increase of the CREB signal in the D2R-
Sigma1R cells. These dynamic changes in D2R-Sigma1R signalling 
produced by cocaine maybe explained by synergistic allosteric 
receptor-receptor interactions in the D2R-Sigma1R heteroreceptor 
complexes at the plasma membrane level. An antagonistic allosteric 
receptor-receptor interaction between the dopamine D2R and the 
Sigma1R in absence of cocaine instead of can explain the reduced 
potency of quinpirole. These dual conformational changes in the 
D2R-Sigma1R heteroreceptor complexes could be associated with the 
redistribution of both protomers from the intracellular compartment 
to the plasma membrane as indicated by means of confocal analysis 
of agonist induced D2RSigma1R traffi  cking and internalization. Overall, 
the dynamic of D2R-Sigma1R heteroreceptor complexes may represent 
a mechanism that shapes neuronal and addictive responses to cocaine.
Keywords Dopamine D2 receptor, Sigma 1 receptor, heteroreceptor 
complexes
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Autism spectrum disorder (ASD) aff ects 0.9% of children and it is 
recognized as the most genetic of all developmental neuropsychiatric 
syndromes. Mutations in NEGR1 and FGFR2 genes have been recently 
identifi ed as ASD candidates. Negr1 is a member of IgLON adhesion 
protein family but its functions are largely unknown. Our original 
approach has identifi ed Negr1 as a developmentally regulated 
synaptic protein. Thus we examined the consequences of Negr1 acute 
downregulation. Strikingly, we found that Negr1 ablation impairs 
neuronal maturation in vitro1. A combination of biochemical and 
imaging investigation has demonstrated that Negr1 infl uences neurites 
outgrowth via MAPK signaling organizing trans-synaptic heterodimer. 
In detail, we demonstrated that ectopic Negr1 is suffi  cient to improve 
neurite arborization and rescue the morphological phenotype 
observed in Negr1 KD cells. This function is dependent on the activation 
of MAPK pathway through tyrosine kinase receptors. In fact, we found 
that Negr1 physically and functionally interacts with NCAM and FGFR2, 
modulates FGFR2 response to FGF and consequently infl uences MAPK 
pathway. FGFR2/NCAM pathway plays an important role during brain 
development. Not surprisingly, our investigation of the radial migration 
of newly generated cortical neurons, revealed that Negr1-FGFR2-
NCAM cross-talk controls cortical organization in vivo. Connectivity 
dysfunctions have been suggested as causative alterations in ASD. 
Given the functional, physical and genetic correlation among Negr1 
and FGFR2 and NCAM, the study of Negr1/FGFR2/NCAM molecular 
cross talk may off er new therapeutic opportunities.
Keywords Autism, Negr1, MAPK
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Hepatic encephalopathy (HE) is manifested by impaired glutamatergic 
transmission. The current view is that HE spares the glutamatergic 
synapse, its dysfunction being primarily due to impaired astrocytic 
control. Here we show that in acute HE, the glutamatergic synapse 
by itself presents discrete changes in the ultrastructure (electron 
microscope) and expression of functionally critical synaptic proteins 
(Western blot). We used C57Bl6 mice subjected to a hepatotoxic insult 
in the azoxymethane (AOM) model. Cerebral cortex of AOM mice was 
ultrastrcturally characterized by the presence of increased numbers 
(~by 15%) of enlarged synapses showing abundance of synaptic 
vesicles in the presynaptic zone. The expression of synaptophysin 
and synaptotagmin in S2 fraction was increased by ~80% and ~30%, 
respectively. The expression of the NR1 subunit of NMDA receptor, 
but not of NR2A, was slightly increased. The amount of PSD-95 in P2 
fraction and nNOS in S2 fraction, were elevated by ~40% and ~30% 
respectively. The expression of PKCζ was increased by ~30% and ~40% 
at the mRNA and protein level, respectively. PKCζ protein level was 
reduced by ~20% in P2 membrane fraction and elevated by ~30% in 
S2 cytosolic fraction suggesting its altered intracellular traffi  cking. This 
report is to our knowledge the fi rst to demonstrate distinct changes in 
the synaptic ultrastructure and composition of synaptic proteins in the 
acute stage of HE. Except for PKCζ, all the other changes are indicative 
of a compensatory response of as yet unknown functional implications.
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Ubiquitin-proteasome system (UPS) represents important intracellular 
system controlling protein quality and intracellular signalling. Overload 
or dysfunction of UPS leads to proteasome stress that is implicated in 
mechanisms of neurodegeneration associated with neurodegenerative 
diseases, e. g. Parkinson and Alzheimer disease. Proteasome stress is 
also considered as the main cause of delayed neuronal death observed 
after transient global brain ischemia. Despite signifi cant progress made 
to date, the exact mechanism and selectivity of cell death induced by 
proteasome stress after global brain ischemia is still not completely 
understood. The aim of our work was to study eff ect of proteasome 
stress on cell viability, stress response as well as on mechanism of death 
of neuroblastoma SH-SY5Y and glioblastoma T98G cells. Proteasome 
stress was induced by treatment of cells with bortezomib, inhibitor of 
proteasome 26S complex. Neuroblastoma cells were more sensitive to 
bortezomib than glioblastoma cells and death of neuroblastoma cells 
occurred signifi cantly faster than death of glioblastoma cells. With respect 
to cellular response, treatment of both SH-SY5Y and T98G cells with 
bortezomib was associated with accumulation of polyubiquitinylated 
protein aggregates and increased expression of HSP70. With respect 
to cell death mechanism, we have documented bortezomib-induced 
release of cytochrome c from mitochondria and activation of caspase 3 in 
SH-SY5Y cells. In T98G cells, bortezomib induced activation of caspase 4 
but not caspase  3 and did not induce release of cytochrome c from 
mitochondria. Our results indicate that proteasome stress aff ects neural 
cells in diff erent way but does not answer the question about selectivity 
and delay of cell after global brain ischemia.
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Mitophagy is a selective degradation of mitochondria that promotes 
the turnover of mitochondria and prevents the accumulation of 
damaged organelles. Pink1 and Parkin proteins are crucial in the 
removal of damaged mitochondria. Mutations in the corresponding 
PINK1 and PARK2 genes are associated with Parkinson’s disease (PD), 
and mitochondrial impairments are central to PD pathogenesis. Pink1 
has been shown to interact with the atypical Rho GTPases Miro, the 
outer mitochondrial membrane proteins involved in mitochondrial 
traffi  cking. Miro1 is degraded shortly after mitochondrial damage 
in a Parkin-dependent manner. α-synuclein is a major component of 
Lewy bodies, the characteristic cellular inclusions in PD. Mutations of 
α-synuclein, including A53T, are linked to familial PD. α-synuclein has 
been shown to bind to the mitochondrial membrane, and increased 
membrane-bound α-synuclein in PD contributes to the functional 
disturbance of mitochondria. Overexpression of A53T-mutated 
α-synuclein has been shown to induce mitophagy in vitro and in vivo. 
We hypothesized that Miro1 function is disturbed in an α-synuclein 
(A53T)-overexpressing model, and the aim of this study was to 
elucidate the involvement of Miro1 in α-synuclein-induced mitophagy. 
We have found that α-synuclein is one component of the Miro1 
interactome. Moreover, co-expression of Miro1 restored mitochondrial 
length and density in primary neuronal culture overexpressing A53T-
mutated α-synuclein. Miro1 overexpression did not change the 
basal mitophagy, but decreased signifi cantly α-synuclein-induced 
mitochondrial removal. Together, our results suggest that Miro and 
α-synuclein may interact in the mitophagic pathway.
Keywords Mitochondria, autophagy, Parkinson’s disease
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Mammalian neurodevelopment is characterized by qualitative and 
quantitative changes in plasma membrane glycosphingolipids 
due to a fi ne regulation of their metabolic pathways. While the 
biosynthetic pathway is largely studied scant is the information 
available on the catabolic one. For this reason, I studied the activity of 
the main glycohydrolases expressed in the central nervous system 
during neuronal diff erentiation. To this purpose the activities of the 
principal glycohydrolases involved in glycosphingolipid catabolism 
have been evaluated in diff erent experimental models such as brains 
and cerebella of mouse at diff erent ages and neuronal cell cultures 
(immortalized mouse neuronal cell lines GN11 and GT1-7, primary 
cultures of mouse cerebellar granule cells and human neuroblastoma 
cells SH-SY5Y). The results obtained indicate that the process of neuronal 
diff erentiation is associated with a marked increase in the activities of 
all the glycohydrolases evaluated, in particular, the activity of the non-
lysosomal β-glucosylceramidase GBA2 undergoes the most relevant 
increase representing the prevalent form of β-glucocerebrosidase in 
mature neurons. In order to evaluate the possible role of GBA2 in the 
neuronal diff erentiation, SH-SY5Y cells have been stably trasfected for 
GBA2 overexpression. Cells overexpressing GBA2 acquired a neuronal 
phenotype and showed a signifi cant increase in ceramide levels. These 
results are in line with literature data that demonstrate the involvement 
of ceramide in the neuronal diff erentiation. Therefore, it is possible 
to hypothesize that the hydrolysis of glucosylceramide to ceramide, 
catalyzed by GBA2 at the plasma membrane level, has a functional role in 
the neuronal diff erentiation process. Collectively these fi ndings suggest 
that GBA2 may represent a possible neuronal marker and demonstrate 
for the fi rst time its direct involvement in the neuronal diff erentiation.
Keywords Sphingolipids, neuronal diff erentiation, GBA2
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Tianeptine is an atypical antidepressant drug with proven effi  cacy, but 
still not fully understood mechanism of action. Recently it has been 
suggested that tianeptine may modulate infl ammatory processes, 
however there is a lack of data on its infl uence on microglia – the main 
source of pro-infl ammatory cytokines in the brain. Therefore this project 
aimed to investigate whether tianeptine can infl uence activation of 
microglial cells. We conducted our study in two experimental models: 
in vivo – in the hippocampus and frontal cortex of adult rats and in vitro 
in microglial cultures. Pregnant rats were subjected daily to 3 stress 
sessions from 14th day of pregnancy until delivery. Control pregnant 
females were left undisturbed in their homecages. Microglial cells 
were pre-treated for 30 min with diff erent concentrations of tianeptine 
and stimulated with LPS (100  ng/ml). Next, expression of microglial 
activation markers and pro-infl ammatory cytokines were evaluated. In 
the second part of experiments at 3  months of age, after behavioral 
verifi cation, control and prenatally stressed rats were injected with 
tianeptine (10 mg/kg i.p.) for 14 days. Next, biochemical studies were 
carried out on hippocampus and frontal cortex. We observed that 
in microglial pre-treatment with tianeptine (1–10  μM) reduced the 
expression of microglial activation markers (CD40 and MHCII) and 
production of pro-infl ammatory cytokines. Moreover, in adult animals 
subjected to prenatal stress (an animal model of depression) chronic 
tianeptine treatment inhibited microglial activation (decreased CD40 
and CD68 expression) in both examined structures. In conclusion, 
our results show that tianeptine exerts anti-infl ammatory properties 
suppressing microglial activation in both in vitro and in vivo 
experimental models.
Acknowledgements This research was supported by grant no. 
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Introduction Alzheimer’s disease (AD) is an incurable neuro-
degenerative disease characterized by progressive dementia. Main 
neuropathological features of AD include extracellular β-amyloid (Aβ)-
containing plaques, intraneuronal aggregates of hyperphosphorylated 
τ-protein and neurofi laments, microglial activation and clustering 
around Aβ plaques and synaptic loss. 5XFAD transgenic mice are 
a model of AD, exhibiting rapid brain accumulation of Aβ and 
microgliosis. The aim of the study was to characterize the eff ects of 
streptozocin (STZ)-indced diabetes on learning and memory of 5XFAD 
and wild-type (WT) mice in Morris water maze (MWM) at ages 2 and 6 
months and on brain amyloid load.
Methods and results Mice were injected with STZ 90 mg/kg or vehicle 
i.p., once daily for 2 consecutive days. MWM was performed on week 9 
and histological analysis of brains of mice injected with STZ or vehicle 
at 2 months of age was performed on week 16. STZ treatment did not 
aff ect locomotion or vision of mice in MWM. At both 2 and 6 months of 
age, STZ treatment impaired memory of both 5XFAD and WT. Learning 
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was signifi cantly impaired in STZ-treatedc 5XFAD mice at 2 months. 
Surprisingly, Congo Red-positive area fraction (%) of hippocampus and 
amygdala was decreased 5XFAD mice treated with STZ at 2  months. 
Plaque diameter was not diff erent between STZ treated and vehicle 
treated 5XFAD mice.
Conclusions Insulin defi ciency could aff ect cognition through 
mechanisms unrelated to Aβ metabolism. Also diff erent mechanisms 
may underlie eff ects of STZ treatment on learning and memory in 
diff erent age groups, possibly including enhancement of brain amyloid 
deposition and inhibition of neural cell precursor proliferation. We also 
hypothesize that STZ treatment might increase the soluble brain amyloid 
fraction in this model, since it is currently acknowledged that oligomeric 
(soluble) rather than fi brillar Aβ species disrupt cognitive function in AD.
Keywords Amyloid, diabetes, Alzheimer’s
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Oxidative stress is a key mechanism of cellular damage during and 
after severe hypoxia. Accordingly, up-regulation of expression and 
activity of endogenous antioxidants is an important mechanism of 
cellular adaptation to hypoxia. Do endogenous antioxidants take part 
in postconditioning-induced neuroprotective mechanisms similarly 
to their participation in preconditioning-induced ones? In the present 
work the eff ect of postconditioning by 3-trial mild hypobaric hypoxia 
(360 Torr, 2  h, once a day) after 1  session of severe acute hypobaric 
hypoxia (180 Torr, 3 h) on the expression of Cu, Zn-superoxide dismutase 
(Cu, Zn-SOD) was studied by immunocytochemical analysis in areas CA1, 
CA2, CA3, CA4 and DG of hippocampus and in frontoparietal neocortex 
(NC) of male Wistar rats. Two time points were examined: 3 h after the 
last session of postconditioning that was 3 days after severe hypoxia 
and 24 h after the last session of postconditioning that was 4 days after 
severe hypoxia. It has been shown that postconditioning signifi cantly 
increases the total number of Cu, Zn-SOD-immunoreactive cells (Nt) at 
least in two areas of hippocampus studied (CA2 and DG) compared to 
non-postconditioned rats at 3 days but not at 4 days after severe hypoxia. 
In contrast, in NC of postconditioned rats, Nt tends to increase compared 
to non-postconditioned animals at 4 days but not at 3 days after severe 
hypoxia. The eff ect of postconditioning on the number of intensely 
expressing Cu, Zn-SOD neurons diff ers in various areas and at various 
time points. The modifi cation of Cu, Zn-SOD expression in some areas 
of hippocampus and NC, induced by 3-trial hypoxic postconditioning, 
correlates with the prevention of massive delayed apoptotic neuronal 
death and amelioration of functional disorders caused by severe 
hypoxia. Thus, Cu, Zn-SOD and other endogenous antioxidants may 
play, apparently, an important role in the treatment of severe hypoxia/
ischemia stroke by postconditioning in brain neurons.
Keywords Postconditioning, hypoxia, Cu, Zn-superoxide dismutase
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In addition to glucose, also fatty acids are important as an energy 
source in the brain where about 20% of the energy is gained from 
mitochondrial oxidation of fatty acids. Fatty acids are transported into 
mitochondria in the form of acylcarnitine. It is known that acylcarnitine 
concentration in the heart and blood plasma varies depending on 
the nutritional state, fed or fasted. The aim of the present study was 
to compare the concentration of short-chain (C2-C5), medium-chain 
(C6-C12) and long-chain (C14-C18) acylcarnitines in fed and fasted 
states in rat brain structures: cerebellum, cortex and hypothalamus. 
The total concentration of acylcarnitines was not aff ected by nutrient 
state in none of brain structures studied, but we found that cortex 
contained less acylcarnitines than cerebellum and hypothalamus.
The nutritional state did not aff ect the overall concentration of short-
chain acylcarnitines in the brain structures.In contrary, the nutritional 
state signifi cantly aff ected the concentration of total medium chain 
acylcarnitines in the cortex: 0.33 and 0.46  nmol/g tissues in fed and 
fasted state, respectively. The highest concentration of medium-chain 
acylcarnitines was found in hypothalamus in fed and fasted state 
compared to cortex and cerebellum. The nutritional state signifi cantly 
aff ected the concentration of total long-chain acylcarnitines in the 
cortex: 4.92 and 5.88 nmol/g tissues in fed and fasted state, respectively. 
In fed state the highest concentrations of long-chain acylcarnitines 
was found in hypothalamus compared to cortex and cerebellum. The 
results demonstrate that the nutrition state aff ects brain acylcarnitine 
concentration in diff erent brain structures, and cortex is the most 
aff ected brain structure. Further studies are needed to investigate the 
role of changes in acylcarnitine profi le in the brain signalling pathways.
Acknowledgements The study was supported by European Social 
Fund project No. 1DP/1.1.1.2.0/13/APIA/VIAA/009.ISN travel award
Keywords Acylcarnitine, brain structures, nutritional state
P47
Janus-faced taurine: protection or toxicity?
Andrey Taranukhin, Pirjo Saransaari, Simo Oja
School of Medicine, University of Tampere, Finland
SpringerPlus 2015, 4(Suppl 1):P47
Taurine is a simple sulfur-containing amino acid ubiquitously dis tri buted 
in the tissues of most animals. It is involved in a wide range of physiological 
processes including osmoregulation, lipid metabolism, intracellular 
calcium regulation, neuronal development, neuromodulation and cell 
protection. Using in vivo model of acute ethanol intoxication (5  g/kg) 
in 7-day-old mice we have found that taurine treatment at total dose 
2  g/kg has saved about 50% of dying neurons from ethanol-induced 
apoptosis in the internal (Taranukhin et al, 2009, 2010) and the external 
(Taranukhin et al, 2012) granular layers of developing cerebellum. 
However, any further increase in taurine doses (4–6  g/kg) aiming to 
protect more neurons against alcohol-induced apoptosis poses to threat 
to the whole organism and kills 7-day-old mice thus treated. Since the 
high doses of taurine alone or ethanol alone did not lead to animal 
death, lethality appears to be due to ethanol and taurine combined 
toxicity. We reveal the 50% and 100% lethal doses of taurine and ethanol 
combination for developing (7-day-old), adult (5–6-month-old) and old 
(12–13-month-old) mice and can conclude that the toxicity of ethanol 
and taurine combination is age-dependent. A dramatic drop in blood 
glucose levels observed in 25% of 7-day-old and 40% of elderly mice 
treated with taurine and ethanol suggests that one of the reason of 
animal death may be hypoglycemia (Taranukhin et al., 2013, 2015). Based 
on the results obtained we conclude that taurine may have benefi cial 
eff ects in protecting brain cells against the apoptosis induced by alcohol. 
However, our fi nding on the toxicity of combined taurine and ethanol 
prompts serious concern particularly for young people mixing taurine-
containing energy drinks with alcohol.
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Mutations in WFS1 gene cause Wolfram syndrome, which is a rare 
autosomal recessive disorder, characterized by diabetes insipidus, 
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diabetes mellitus, optic nerve atrophy and deafness (DIDMOAD). WFS1 
gene product wolframin is located in the endoplasmic reticulum. Mice 
lacking this gene have disturbances in processing and secretion of 
peptides, such as vasopressin and insulin. In the brain, high levels of 
wolframin protein are observed in the hippocampus, amygdala and 
limbic structures. The aim of this study was to investigate the eff ect of 
Wfs1 invalidation on the peptide processing in hippocampus of mice. 
Peptidomic approach was used to characterize individual peptides in 
the hippocampus of wild type and Wfs1 knock-out mice. We identifi ed 
126 peptides in the hippocampal extracts and levels of 10 peptides were 
diff erent in Wfs1 and wild type mice at (p < 0.05). Largest alteration was 
found in the level of peptide little-LEN, which is processed (cleaved) 
from pro-SAAS (Pcsk1n) in prohormone convertase 2 (PC2) dependent 
ways. Results of this study reveal alterations of peptide processing in 
the hippocampus of Wfs1 defi cient mice.
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Development of the nervous system and its structural remodelling 
in the adult relies on molecules mediating the structural plasticity 
of neurons, e specially those involved in cell adhesion, cytoskeletal 
dynamics or synapse formation. Neural cell adhesion molecule (NCAM) 
is a membrane-associated glycoprotein that can be modifi ed by 
glycosylation with polysialic acid (PSA), attenuating NCAM-mediated 
cell interactions, thereby promoting structural plasticity [1]. It has been 
demonstrated that in conditions of neuroinfl ammation, NCAM can be 
cleaved extracellularly by metalloproteinases and other proteolytical 
enzymes. Prolyl endopeptidase (PREP) is a cytosolic serine protease, 
and alterations in PREP expression and activity have been associated 
with neuronal death and neuroinfl ammation [2]. Since the precise 
mechanisms and possible partners of PREP in neuroinfl ammation 
remain unclear, the aim of this study was to determine whether increased 
secretion and activation of PREP could impair NCAM expression and its 
polysialylation. SH-SY5H cell line overexpressing (o/e) PREP was used 
as an in vitro model for increased PREP expression and extracellular 
release. When measuring expression levels of NCAM and PSA-NCAM we 
found remarkable loss in PSA-NCAM and disrupted expression patterns 
of NCAM compared to wild-type cells. As matrix metalloproteinase 9 
(MMP-9) has been indicated in processes regulating shedding of PSA-
NCAM, MMP-9 expression level was measured. An increase in the level 
of the active form of MMP-9 was found, which was counteracted by 
a specifi c inhibitor of PREP, KYP-2047. As demonstrated, PREP might 
have an important role in processes involved in NCAM degradation 
and polysialylation, thereby inducing progression of pathologies 
associated with altered neuroplasticity.
Keywords Neural cell adhesion molecule, prolyl endopeptidase, 
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Corticosterone (CORT) is the main glucocorticoid hormone involved 
in stress responses in rodents. It is established that CORT exerts its 
eff ects via glucocorticoid receptor (GR) and mineralocorticoid receptor 
that regulate downstream gene expression during development 
and adulthood. In our previous study, we have shown that maternal 
separation on postnatal day  15 increases DNA methyltransferase 
(DNMT) 1, 3A and 3B expression levels in rat nucleus accumbens lasting 
into adulthood (Anier et al. 2014). However, the exact mechanism how 
maternal separation alters DNMT expression is unclear. We hypothesize 
that stress-induced GR stimulation may increase the expression 
levels of DNMTs and alter long-term DNA methylation-demethylation 
balance in infant rat brain. Our aim is to evaluate the eff ect of CORT 
and maternal separation on the expression levels of DNMTs in rat 
cortex. In rat primary cortical neurons, CORT treatment increased 
mRNA levels of DNMT3A and DNMT3B. GR antagonist mifepristone 
signifi cantly decreased CORT-induced DNMTs mRNA levels indicating 
GR stimulation-dependent upregulation of DNMTs expression. Higher 
mRNA levels of DNMT1, DNMT3A and DNMT3B in rat cortex at postnatal 
day 15 and increased plasma CORT levels suggest that elevated CORT 
upregulates DNMTs expression. Our results indicated that DNMTs are 
downstream targets of GR-dependent CORT stimulation and early 
life stress may induce aberrant DNA methylation pattern that could 
facilitate long-term changes in gene expression.
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Background The Sigma-1 receptor is a chaperone protein that modulates 
intracellular calcium signalling of the endoplasmatic reticulum and is 
involved in learning and memory processes. The aim of the present study 
was to compare in vitro Ca2+ concentration modulating activity and in 
vivo behavioural eff ects of enantiomers of methylphenylpiracetam, a 
novel positive allosteric modulator of Sigma-1 receptors.
Methods The activity of enantiomers was compared in the model 
of electrically stimulated rat vas deferens and bradykinin-induced 
intracellular Ca2+ concentration ([Ca2+]i) increase assay in neuro-
blastoma-glioma (NG-108) hybrid cells, PRE-084 was used as a selective 
Sigma-1 receptor agonist. Eff ects on contextual memory, locomotor 
activity and antidepressant activity were evaluated in ICR male mice 
in passive avoidance (PA) response, open fi eld and Porsolt forced 
swimming tests, respectively. The rota-rod, traction and chimney tests 
were used to screen eff ects of the compounds on muscle function and 
coordination.
Results Enantiomers with R-confi guration at the C-4 chiral centre in 
the 2-pyrrolidone ring both signifi cantly increased PRE-084 activity in 
vitro and almost two-fold increased the retention time in the PA test 
in vivo. The behavioural side eff ects were slightly more expressed for 
the enantiomers with S-confi guration at the C-5 chiral centre. The 
enantiomers of methylphenylpiracetam did not induce any signifi cant 
eff ects on the locomotor and depressive condition in the mice.
Conclusions Pharmacological stimulation of sigma-1 receptor is an 
emerging approach for cognition enhancement. The R-confi guration 
enantiomers of methylphenylpiracetam are more active positive 
allosteric modulators of Sigma-1 receptor than S-confi guration 
enantiomers. The Sigma-1 receptor modulatory activity of compounds 
correlated with the memory enhancing eff ects.
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Implementation of fl uorescence methods in studies of ligand 
binding to their receptors opens new possibilities to characterise 
these processes. One of the potential approaches is the detection of 
changes of the fl uorescence anisotropy (FA) and/or total fl uorescence 
intensity (TFI) signals upon binding reaction. However, to achieve 
signifi cant changes in the FA/TFI signal, some requirements need to 
be met  – the concentration of receptor binding sites as well as the 
dissociation constant of the interaction should be in the same order 
as the fl uorescent ligand’s concentration. We have used FA assay 
to investigate ligand binding properties to Melanocortin 4 (MC4) 
receptor [1]. Implementation of budded baculoviruses (BBV) that 
display G protein-coupled receptors on their surfaces signifi cantly 
increased sensitivity and temporal stability of this assay [2]. For the fi rst 
time we demonstrate the applicability of BBV experimental setup to 
study Y1 receptor system. Here we used TAMRA-PYY, an Y1 receptor 
specifi c fl uorescent peptide ligand, as a reporter ligand. Besides real-
time monitoring of FA signal changes, up to 5 fold decrease in TFI 
signal was observed within TAMRA-PYY binding to the Y1 receptor. 
Pharmacological characterization of Y1 receptors with receptor-
specifi c unlabelled ligands gave the rank order of potencies consistent 
with previously reported values. Additionally, allosteric heterogeneous 
interactions were revealed as koff  values of TAMRA-PYY diff ered more 
than 7 times depending on the nature of dissociation initiated ligand. 
These observations provide evidence for similar allosteric receptor-
ligand binding mechanism as previously shown for MC4 receptors [3].
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Excitotoxicity following cerebral ischemia elicits a molecular cascade, 
which leads neurons to death. One key molecule of this pathway 
is c-Jun-N-terminal kinase (JNK), a MAP kinase, which plays both 
physiological and pathological roles in neurons. We have previously 
shown that JNK blockade by specifi c cell permeable peptide inhibitors 
signifi cantly reduces infarct size and neuronal death. On the other 
hand, JNK inhibition may have detrimental side eff ects due to blockade 
of its physiological function. Here we have designed a new inhibitor, 
which blocks MKK7, an upstream activator of JNK, which mediates its 
pathological activation. This inhibitor was designed taking advantage 
of the growth arrest and DNA damage inducible 45β (GADD45β) ability 
to bind MKK7, optimizing the essential domain of GADD45β and 
linking it with a spacer to TAT peptide sequence to penetrate cells. This 
inhibitor signifi cantly reduces neuronal death in two in vitro models 
of excitotoxic cell death, one induced by NMDA exposure and the 
other by oxygen glucose deprivation. We tested the MKK7 inhibitor 
in vivo, in two models of permanent ischemia, the one obtained by 
electrocoagulation, and the other by thromboembolic occlusion of the 
Middle Cerebral Artery. In both models, it blocked MKK7 activation and 
provided signifi cant protection, signifi cantly reducing the infarct size 
when injected 30’ before the lesion. In the electrocoagulation model, 
we also tested the effi  cacy of the peptide when injected 6h after lesion, 
obtaining similar protection. Therefore, we showed that it is possible to 
prevent JNK activation in excitotoxicity by specifi c inhibition of MKK7, 
preserving the physiological role of JNK driven by MKK4. Targeting 
MKK7 could represent a novel therapeutic strategy for several diseases 
involving JNK activation.
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Postconditioning (PostC) is an exposure of the damaged organism 
to extreme factors of the mild intensity to mobilize endogenous 
protective mechanisms. In our laboratory method of PostC using 
three daily trials of mild hypobaric hypoxia (MHH) was developed. It 
has been found that such method of the PostC eff ectively prevents 
degeneration of the hippocampal and neocortical neurons in rats, 
subjected to severe hypoxia (SH). Present study has been aimed at 
examination of the impact of oxidative processes in the development 
of the neuroprotection acquired in the course of hypoxic PostC 
during fi rst three days of reoxygenation after SH in rats. The levels of 
thiobarbituric acid reactive substances (TBARS) and Schiff  bases (SB) 
were used as markers of lipid peroxidation. In addition, the intensity of 
the apoptotic DNA fragmentation has been studied. During the three 
days after the SH a sustained increase of SB in the rat hippocampus 
was observed (700–1000% of the control value). After the fi rst PostC 
episode the SB levels decreased to 150% of the baseline. Subsequently 
this parameter did not diff er signifi cantly from the control values. 
TBARS showed accumulation on the fi rst day following the SH but 
afterwards its levels dropped to 40% of control and did not recover 
then to normal values. In the PostC animals, the levels of TBARS after 
each of three PostC episodes did not diff er from the control values. 
These facts indicate that the PostC MHH balances the activity of pro- 
and antioxidant systems in vulnerable brain regions and promotes 
the eff ective utilization of components damaged by peroxidation. 
Fragments ladder typical for cells undergone apoptosis was obtained 
by the electrophoretic separation of the total DNA, extracted from a 
rat brain after one, two and three days after the SH. In the PostC group, 
the DNA fragmentation was revealed only after the fi rst PostC episode, 
demonstrating antiapoptotic action PostC MHH.
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Extracellular matrix (ECM) forms the pericellular part of the tissue. Due 
to the ECM’s constitution it defi nes the biophysical and biochemical 
properties of the tissue. In vertebrates’ brain the neuronal ECM mainly 
consists of negatively charged chondroitin sulfate proteoglycans 
(CSPG), hyaluronan and glycoproteins. CSPG are supposed to be 
involved in cell adhesion, axonal pathfi nding and receptor binding. 
Therefore they are considered to play a role in neural development and 
plasticity as well as in several neurological and psychiatric disorders 
(e.g. schizophrenia and depression). One member of the CSPG family 
is brevican which was previously demonstrated by Blosa et al. (2013) to 
SpringerPlus 2015, Volume 4 Suppl 1 
http://www.springerplus.com/supplements/4/S1
Page 31 of 32
occur adjacent to the active zone of synapses. Accessorily, defi ciency 
in brevican was reported to lead to a reduction of hippocampal LTP 
and recruitment of local plasticity. In this study we therefore focused 
on the eff ect of brevican on the neuronal cell adhesion molecule 
NCAM and its polysialylated form PSA-NCAM. Both of them are known 
to be involved in the establishment and modulation of neuroplasticity 
which are essential for memory formation. Furthermore we analysed 
the expression of the prolyl endopeptidase PREP, the matrix 
metalloproteinase  9 (MMP9) and tissue inhibitors of MMPs (TIMP). 
Immunohistochemical and western blot analyses of hippocampus 
tissue of brevican knockout mice compared with wild type littermates 
did not reveal changes in the expression of MMP9, PREP, NCAM nor PSA-
NCAM, but showed a reduction of TIMP1 and 3 by trend. Consequently, 
changes of LTP and local plasticity in brevican defi cient mice do not 
seem be mediated by an alteration of NCAM and PSA-NCAM, but might 
be supported by diff erent expression levels of TIMP 1 and 3 modulating 
several MMPs’ activity.
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Neuromelanins (NM) are a family of compounds occurring in all brain 
regions of human brain. These pigments are contained in special 
lysosomes together with lipid bodies, protein matrix, and accumulate 
in aging (Zucca et al. Neurotox Res. 2014). The synthesis of NM is a 
protective process because the melanic component is generated 
through the removal of reactive/toxic quinones that would otherwise 
cause neurotoxicity (Sulzer et al. PNAS 2000). NM serves an additional 
protective role through its ability to chelate and accumulate metals, 
including environmentally toxic metals such as mercury and lead. Other 
metals like Fe, Zn, Al, Cr and Mo are also accumulated by NM (Zecca et 
al. PNAS. 2008). However NM can play also a toxic role in Parkinson’s 
disease (PD), when it is released by dying neurons of substantia nigra. 
Extracellular NM particles induce microglial activation with production 
of superoxide, nitric oxide, hydrogen peroxide, pro-infl ammatory 
factors and causes neurodegeneration (Zhang et al. Neurotox Res. 
2011). A high content of major histocompatibility class I complex 
(MHC-I) was found in NM-containing organelles of the neurons in 
substantia nigra (SN) and locus coeruleus (LC) which degenerate in 
PD, while other neurons not targeted by PD has low MHC-I. The latter 
can bind antigens derived from foreign proteins, presenting them 
on neuronal membrane. Then CD8+ cytotoxic T-cells, which were 
observed in proximity of MHC-I presenting neurons of SN and LC in PD 
subjects, can target these neurons inducing neuronal death. Infi ltration 
of T-cells occurs in SN and LC of PD subjects. The presence of MHC-I 
in catecholamine neurons containing NM could explain their selective 
vulnerability in PD, revealing a novel infl ammatory T-cell mediated 
neurodegenerative process of PD (Cebrián et al. Nat Commun. 2014). 
In conclusion NM can play a protective or toxic role depending on the 
molecular/cellular context.
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Caspases are known to play an important role in apoptosis and 
their increased activity in pre- and postsynaptic terminals leads to 
proteolysis of synapse-associated proteins, resulting in disruption 
of synaptic functions. Moreover, caspases degrade the C-terminal 
fragment of amyloid-precursor protein intracellular domain (AICD) 
which regulates expression of a variety of genes including an amyloid-
degrading enzyme neprilysin (NEP). As such, inhibition of caspases 
is considered as a tool for prevention and compensation of various 
synaptic pathologies leading to cognitive defi cit and Alzheimer’s 
disease pathogenesis. In this study we have evaluated the role of 
prenatal hypoxia on the activity of caspases and neuronal network 
characteristics in rat brain and the eff ect of caspase inhibitors on these 
parameters. We have found that the brain of rats subjected to prenatal 
hypoxia (Е14, О2 7%, 3 h) is characterised by an increased number of 
caspase-3-positive neurones and higher activity of this enzyme in the 
neocortex and hippocampus in the period of intensive synaptogenesis 
(Р20-30) compared to controls. Subsequently, in later life these animals 
had a reduced number of synaptopodin-positive dendritic spines 
and reduced activity of NEP accompanied by disruption of cognitive 
functions. Single i.v. injection of caspase-3 inhibitors (Ac-DEVD-CHO) 
to hypoxic rats on Р18-23 led to a decrease in caspase-3 activity and 
increased NEP expression. In these animals we have also observed 
restoration of synaptopodin levels and distribution of the labile synaptic 
spines in the neocortex and hippocampus which were accompanied by 
improved memory. The eff ects of inhibitors on memory was observed 
within one month after administration but not detected 2.5  months 
later. These data testify to the involvement of caspase-3 in normal 
brain development and indicate an important role of this enzyme in 
neuronal plasticity and regulation of cognitive functions.
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